Mechanotransduction through adhesion molecules: Emerging roles in regulating the stem cell niche

Abstract

Stem cells have been shown to play an important role in regenerative medicine due to their proliferative and differentiation potential. The challenge, however, lies in regulating and controlling their potential for this purpose. Stem cells are regulated by growth factors as well as an array of biochemical and mechanical signals. While the role of biochemical signals and growth factors in regulating stem cell homeostasis is well explored, the role of mechanical signals has only just started to be investigated. Stem cells interact with their niche or to other stem cells via adhesion molecules that eventually transduce mechanical cues to maintain their homeostatic function. Here, we present a comprehensive review on our current understanding of the influence of the forces perceived by cell adhesion molecules on the regulation of stem cells. Additionally, we provide insights on how this deeper understanding of mechanobiology of stem cells has translated toward therapeutics.

1 Introduction

Regenerative Medicine, which deals with the restoration of tissues/organs upon injury or chronic disease, is a promising and emerging branch of medical research (Mason and Dunnill, 2008; Mahla, 2016). It is well known that stem cells in our body hold the capability of self-renewal and differentiation into other types of cells, which makes it an ideal candidate for regenerative medicine. Though the term stem cell (original: ‘Stammzelle’) appeared in the scientific literature in the mid-19th century by famous German biologist Ernst Haeckel (Haeckel, 1868); major breakthroughs in the stem cell research only happened a century later. However, over the past 20 years, there have been immense advancements in the field of stem cell research, in elucidating their characteristics and potential for regenerative medicine (Mahla, 2016; Liu et al., 2020).

Although there are different types of stem cells, they all share common characteristics of self-renewal and the ability to differentiate into different cell types. Among many types of stem cell classifications, two common ways to classify them are 1) based on their origin or residency, known as tissue-specific stem cells and 2) based on their potency, which refers to their ability to differentiate into various cell types.

Stem cells isolated from mammalian blastocysts are also known as embryonic stem cells (ESCs) (Evans and Kaufman, 1981; Thomson, 1998; Smith, 2001). Stem cells isolated from the epiblast stage of embryos are termed epiblast stem cells (EpiSCs) and primordial germ cells (embryogenic germ cells EGCs) (Shamblott et al., 1998; Yu and Thomson, 2008). In contrast to ESCs, adult stem cells are found in various tissues and are alternatively termed as somatic stem cells (Leblond, 1964; Robey, 2000). Hematopoietic stem cells (HSC) were amongst the first identified adult stem cells and the most widely studied (Seita & Weissman, 2010). Some of the tissues where pools of adult stem cells have been identified include 1) The nervous system which includes parts of brain, 2) Bone marrow and blood which consist of bone marrow, peripheral blood, dental pulp and spinal cord, blood vessels, 3) Endothelial Progenitor Cells, 4) Skeletal Muscle Stem Cells, 5) Epithelial Cell Precursors in the Skin and Digestive System as well as from parts of cornea, retina, liver, and pancreas. These tissue specific stem cells (TSSCs) behave differently depending on their local environment and the homeostatic requirement of the body.

Stem cells (SCs) often reside in tissue-specific microenvironments termed as the stem cell niche, that play an important role in regulating the proliferation and differentiation of these cells, thereby maintain tissue homeostasis (Schofield, 1978). The concept and significance of the stem cell niche was first proposed by Scholfield in 1978, when he demonstrated that removing these cells from their niche resulted in their differentiation (Schofield, 1978). Stem cell fates are regulated by both intrinsic and extrinsic factors. Cell-intrinsic factors include specific transcription factors, microRNAs, epigenetic regulators and secreted signaling molecules such as Wnts and BMPs (Watt and Hogan, 2000; Nusse, 2008; Gangaraju and Lin, 2009; Wang and Wagers, 2011; Li et al., 2017; Chacón-Martínez et al., 2018; Rigillo et al., 2021). Extrinsic factors include the regulation of stem cells with through cell-cell and cell-substratum interactions (Watt and Huck, 2013; Gattazzo et al., 2014). In addition to the above-mentioned niche factors, mechanical signals originating from cell-intrinsic and externally applied forces also have major implications on the behavior of the SCs (Vining and Mooney, 2017). Force generation by actomyosin contractility and cytoskeletal assembly impinge on mechanisms by which the cells exert intrinsic forces on its extracellular milieu and neighboring cells. In contrast, cell-extrinsic forces arise from the rigidity, topography and composition of the ECM that exerts shear, tensile and compressive forces on the stem cells (Lo et al., 2000; Even-Ram et al., 2006; Dupont et al., 2011; Li et al., 2011; Wolfenson et al., 2019). Transmission of these mechanical forces through cell-cell junctions and cell-substratum adhesions plays a key role in regulating intracellular signaling pathways, eventually determining stem cell fate (Vining and Mooney, 2017). Although the role of cell-intrinsic factors and signaling molecules regulating the quiescence of the stem cells have been extensively studied, the mechanical function of the cell-cell adhesion molecules in maintaining the stem cell homeostasis is less well explored. Cells typically sense and transmit external forces to specialized structures at the cell periphery. These structures then transduce the forces into a biochemically detectable signal, and ultimately the response of the cell is transcribed by the nucleus. These are commonly referred to as mechanotransmission, mechanosensing, and mechanoresponse, respectively or as a whole, mechanotransduction (Ingber, 2006; Jansen et al., 2017). Recent studies have highlighted the importance of biophysical attributes of the microenvironment, including mechanical loading and substrate material property, in determining the self-renewal and commitment of SCs required for its maintenance and differentiation respectively. External forces applied to the SCs from its niche generates traction forces as well as compressive forces through the cytoskeleton. These forces are then transmitted from the cytoskeleton to other cellular components inside or outside of the SCs. This concept of organizing and stabilizing the cytoskeleton by the living cells in response to applied external forces is based on the model of tensegrity, which was first described by D. Ingber (Chen and Ingber, 1999; Ingber, 2003). The cellular tensegrity model describes the cell as a mechanical force bearing structure that is composed of compression resistant components and tension bearing cables. These cables create a pre-stress state in the cell, which is opposed by the compression resistant components known as struts, that aids in the maintenance of the mechanical equilibrium of the cell. This tensegrity-based model highlights the integration of cytoplasmic mechanotransduction and biological responses that are critical for determining the proliferative and differentiative characteristics of SCs, gene expression, as well as its role in organ development (Chowdhury et al., 2010; Engler et al., 2004; 2006). The 2 cell junctions that regulate mechanotransduction of the SCs within its niche are, the cadherin mediated Adherens Junctions (AJs) and the integrin mediated Focal Adhesions (FAs).

2 Role of extracellular matrix molecule and adhesion molecules in regulating mechanotransduction of stem cell niche

2.1 Extracellular matrix and matrix metalloproteinases as a niche factor

2.1.1 Extracellular matrix

The ECM comprises of noncellular components surrounding all the cells in the body, and provides mechanical support via a structural macromolecular network (Murphy-Ullrich & Sage, 2014; Theocharis et al., 2016; Stanton et al., 2019). Mechanical cues from the ECM help to regulate cell phenotypes, motility, biochemistry and matrix production and therefore plays an essential role in tissue remodeling (Jaalouk and Lammerding, 2009; Akhmanova et al., 2015). The components of the ECM that mediate signaling in cells include: collagen, elastin, laminin, fibronectin, hyaluronic acid, chondroitin sulfate and syndecans, as well as soluble components such as cytokines, matrix metalloproteinases, growth factors and proteases (Figure 1) (Hynes, 2009; Mohammed et al., 2019). The physical properties of the ECM such as its rigidity, viscosity, porosity and topography are influenced by the concentration, type, and arrangement of macromolecules (fibers, proteoglycans and glycoproteins). As a result, the ECM may present as a soft or hard substrate (Yue, 2014; Jansen et al., 2015). Multiple studies have suggested the role of ECM stiffness as a major regulatory physical factor in determining stem cell fate (Discher et al., 2005; Paszek et al., 2005; Engler et al., 2006; Even-Ram et al., 2006; Hamidouche et al., 2009; Li et al., 2011; Gandavarapu et al., 2014).

FIGURE 1

2.1.1.1 Collagen

About 30% of the total protein mass in mammals is constituted by collagen, which is also one of the most abundant components of the ECM (Shoulders and Raines, 2009; Ricard-Blum, 2011). The collagen super family comprises 28 members with at least 46 distinct polypeptide chains in vertebrates (Brinckmann, 2005). The primary component of the ECM in vertebrates is collagen I, which consists of stiff, thick and long fibrils that contribute to the structural architecture, shape and mechanical properties of tissues such as tensile strength in skin and resistance to traction in ligaments (Ricard-Blum, 2011). Different collagen types are reported to perform tissue-specific functions. For example, collagen XXII which is present only at tissue junctions (skeletal and heart muscles) and in the skin epithelia acts as an adhesion ligand (Koch et al., 2004). Collagen XIII in bone regulates its formation by coupling bone mass to mechanical use (Ylönen et al., 2005) and collagen VII in skin is critical for maintaining dermal-epidermal adhesion, thus affecting its integrity (Bruckner-Tuderman et al., 1987).

Collagen in the ECM of the stem cell niche plays an important role in determining the proliferative and differentiation potential of the stem cells. Studies have shown that type IV collagen in the basement membrane and hair follicles of the skin provides mechanical support as well as an increase in the proliferative potential of normal human basal keratinocytes (Breitkreutz et al., 2013; Choi et al., 2014). Likewise, in muscle stem cells (satellite cells), alterations of muscle stiffness which is mediated by collagen VI deposition by fibroblasts affects the self-renewal and maintenance of these stem cells (Urciuolo et al., 2013). The mechanical microenvironment of the intestinal crypt cells has been shown to be primarily regulated by type VI collagen via its interaction with the RGD domain of fibronectin (Groulx et al., 2011; Benoit et al., 2012). Altered tissue stiffness in the intestinal crypt cells is associated with increased type VI collagen secretion into the basal lamina. This alteration of the tissue stiffness, in turn, affects integrin focal adhesions, growth factor receptor signaling and acto-myosin and cytoskeletal-dependent cellular contractility (Handorf et al., 2015). Collagen has also been shown to support stem cell properties such as clonogenicity, cell growth and osteogenic differentiation potential (Chen et al., 2007; Linsley et al., 2013; Somaiah et al., 2015; Akhir and Teoh, 2020). The absence of collagen III in mice affects osteoblast differentiation (Volk et al., 2014) whereas the denaturation of collagen I promotes osteoblastic differentiation (Tsai et al., 2010). Taken together, these studies suggested that the structural integrity conferred by collagen in the ECM is implicated in the fate of stem cell proliferation and differentiation in different niches.

2.1.1.2 Elastin

Another important component factor of the ECM along with collagen are the elastin networks that are predominantly found in soft elastic tissues like the skin, blood vessels and lungs (Rosenbloom et al., 1993; Li & Daggett, 2002). Elastin is formed from its monomer, tropoelastin. Tropoelastin is crosslinked at its lysine residues, thereby forming elastic fibers along with microfibrillar proteins such as fibrillin. These elastic fibers are the major contributors to the mechanical properties of elastin (Aaron and Gosline, 1981; Ozsvar et al., 2015). Elastin is predominantly deposited during prenatal development and childhood and is rarely synthesized during adulthood (Ozsvar et al., 2015). 90% of elastin comprises elastic fibers, with the remaining 10% consisting of fibrillin glycoprotein (Mecham, 1991). The primary role of these elastic fibers is to undergo constant stretch-recoil cycles, thus maintaining the structural and functional integrity of the elastic tissues throughout the organism’s lifetime (Ozsvar et al., 2015).

Studies have shown that tropoelastin can promote cell attachment and migration of various cell types such as fibroblasts, mesenchymal stem cells (MSCs) and endothelial cells (Ozsvar et al., 2015). Additionally, tropoelastin has been shown to interact and bind with one of the major cell adhesion proteins, integrins, to promote proliferation in MSCs and HSCs. Specifically, elastin’s interaction with ɑvβ3 and ɑvβ5 integrins on the surface of MSCs, either as surface-bound or as soluble tropoelastin, promotes MSC proliferation. This was attributed to the ability of elastin to convey mechanical signals and modulate gene expression that supports proliferation (Rodgers and Weiss, 2004; Yeo and Weiss, 2019). Tropoelastin-integrin interactions partially contribute to the wound healing process by remodeling the ECM (Ozsvar et al., 2021). Likewise, in the hematopoietic stem cell (HSC) compartment, mechanical characteristics of tropoelastin in the ECM has been shown to be associated with its differentiation (Holst et al., 2010). The tunable elasticity of elastin plays an important role in regulating cell proliferation, differentiation, adhesion and migration.

2.1.1.3 Laminin

Laminins are a family of large multidomain, heterotrimeric glycoproteins that are composed of three different subunits, the α, β, and γ chains. These chains are encoded by 11 genes in humans and form at least 15 trimeric combinations of subunits throughout different tissues (Aumailley et al., 2005). Different combinations of these three subunits confer upon laminins its nomenclature. For example, laminin composed of α2, β1, and γ1 chains is laminin 211 and so on (Kaur and Reinhardt, 2015). Each laminin subunit consists of tandem LE repeats (laminin-type epidermal growth factor-like domains), globular domains interspersed within the LE domains and an α-helical domain which follows after the LE repeats (Beck et al., 1990; Hamill et al., 2009). The α-helical domains of the α, β, and γ subunits wind around each other to produce a trimeric coiled-coil structure (Beck et al., 1990). Laminins (with other components) maintain the structural and functional integrity of the ECM, ultimately affecting cell viability (Armony et al., 2016). Additionally, laminins also influence cell adhesion and migration (Domogatskaya et al., 2012).

Laminins are well known for regulating different stem cell functions such as cell-substratum adhesion, proliferation, migration and differentiation (Iorio et al., 2015). However, there are very few in-vivo reports that highlight the mechanical properties of laminin in maintaining stem cell function. In contrast, in-vitro studies that modulate substrate stiffness and ligand composition to mimic the native elasticity of the stem cell niches have highlighted the role of laminin as a stem cell niche factor. For example, satellite cell renewal from skeletal muscle was promoted when cultured on laminin crosslinked hydrogels (with a stiffness of ∼12 kPa) which mimics the native elasticity of skeletal muscles. This study further reported that muscle satellite cells cultured on laminin functionalized hydrogels contributed to muscle regeneration when grafted into immune deficient mice that partially lacked endogenous satellite cells (Gilbert et al., 2010). Different isoforms of laminin have been shown to be able to direct the differentiation of human induced pluripotent stem cells (hiPSCs) into multiple eye-like tissues. Of note, the E8 fragments of laminin 511 enables the dense concentration of hiPSCs colonies due to actomyosin contraction, which results in cell density YAP inactivation and ultimately leading to retinal differentiation in these colony centers (Shibata et al., 2018). Neural stem and progenitor cells (NSPCs) differentiation towards the oligodendrocyte lineage have been shown to be favored when cultured on laminin coated substrate over fibronectin coated substrate and along with mechanical stimulation by subjecting the cells to a single static stretch (Arulmoli et al., 2015). This oligodendrocyte lineage specific differentiation is preferentially mediated by the integrin α6 laminin binding. These findings correlate with what is known in vivo as laminin is found in high concentrations in a developing brain and is also expressed in the NSPC niches such as the subventricular zone (SVZ) of the lateral ventricles and dentate gyrus (DG) of the hippocampus in an adult brain (Chen et al., 2003; Lathia et al., 2007; Relucio et al., 2012). Thus, mechanical forces resulting from robust cell movements during development and tissue folding of the brain may thus be implicated together with laminin in the ECM to direct NSPC differentiation towards the oligodendrocyte lineage within this niche.

2.1.1.4 Fibronectin

Fibronectin (FN) is a large 440 kDa, multidomain, dimeric glycoprotein which is found in the extracellular milieu of different tissues (Proctor, 1987; Parisi et al., 2020). It is composed of two identical subunits that are joined together by disulfide bonds near the C-terminal regions. Each subunit monomer consists of three different types of repeats, namely FNI, FNII and FNIII (Hynes, 1986; Pankov and Yamada, 2002; To and Midwood, 2011; Adams et al., 2015). FN exists in both soluble and insoluble forms. The soluble FN, also known as plasma fibronectin, circulates in the blood and contributes primarily to tissue repair by forming fibrin blood clots (To and Midwood, 2011). On the other hand, the insoluble FN, also known as cellular FN, is found on cell surfaces and in the ECM (Proctor, 1987; To and Midwood, 2011). FN is also considered as the ‘master organizer’ of the ECM since it helps in organizing other matrix proteins such as collagen, heparin, fibrillin and fibulins (Morla and Ruoslahti, 1992; Chung and Erickson, 1997; Klass et al., 2000; Woods, 2001; Galante and Schwarzbauer, 2007; Kaur and Reinhardt, 2015). The tripeptide sequence Arg-Gly-Asp or RGD present on the FNIII repeat, binds to different integrin subunits and aids in the assembly of FN (Goodman, 2021). These non-covalent interactions help in forming a matured FN network.

Interaction of FN with cell surface receptors such as integrins and syndecans aid in cell adhesion and migration as well as determining cell shape and differentiation. Human mesenchymal stem cells (hMSCs) are known to utilize their own contractile forces and translate environmental cues such as variations in substrate rigidity into differential biochemical signals with the help of stretched FN fibers. hMSCs mediated osteogenesis was shown to be increased upon inhibition of αvβ3 integrin on relaxed FN fibers whereas osteogenesis was decreased upon inhibition of αvβ1 on stretched FN fibers. Thus, the mechanical strain of these FN fibers serves as a checkpoint, where they act as a crucial mechano-chemical signal converter that help the hMSCs to differentiate (Li et al., 2013). Osteogenic differentiation is known to be enhanced with increasing higher substrate stiffness ranging from 0.7 to 80 kPa. Interestingly, when polyacrylamide gels were coated with fibronectin, it stimulated osteogenic differentiation even at a lower substrate stiffness of 25 kPa, at a comparable differentiation rate to that of 80 kPa. These studies indicate that the mechanical properties of ECM components like fibronectin might play a significant role in determining the fate of stem cells (Rowlands et al., 2008). In embryonic stem cells (ES) fibronectin-mediated upregulation of the expression αvβ1 has been shown to promote the fate of cells towards a meso-endodermal lineage (Hayashi et al., 2007; Pimton et al., 2011). Additionally, in adult stem cells, fibronectin can promote differentiation towards a skeletal lineage as opposed to an adipogenic fate (Ogura et al., 2004; Martino et al., 2009; Wang et al., 2010). Interestingly, when differentiated 3T3 adipocytes were cultured on fibronectin, a reduction in the lipogenic gene expression was observed, suggesting that fibronectin also affects the fate of these cells (Spiegelman and Ginty, 1983). In mammalian skin, FN is also known to contribute to the wound healing process. The FN pericellular matrix assembled by fibroblasts senses strain caused by a disruption in tensile homeostasis during wounding. Mechanically regulated interaction between FN and collagen drives the deposition of collagen over FN matrices at the wound bed, which protects the FN matrix from the microenvironmental forces (Patten and Wang, 2021). Although it is known that the interaction between FN and collagen is mechanically regulated, the mechanism for the unfolding of the FN fibrils is less well understood (Gee et al., 2008; Ponmurugan and Vemparala, 2012; Früh et al., 2015; Szymanski et al., 2017a; Szymanski et al., 2017b).

2.1.2 Matrix metalloproteinases

Matrix metalloproteinases (MMPs) are enzymes that cleave components of the ECM such as collagen and laminin, and play an important role in embryonic development, morphogenesis and tissue remodeling (Brenner et al., 1989; Matrisian and Hogan, 1990; Woessner, 1991; Tyagi et al., 1995). MMPs are a growing family of metallo endopeptidases and can be classified as collagenases, gelatinases, stromelysins, matrilysins and, enamelysins (Jabłońska-Trypuć et al., 2016). During development, MMPs help in regulating biophysical cues by degrading and modulating the stiffness of the ECM in different stem cell niches such as MSCs and HSCs (Caiazzo et al., 2016; Saw et al., 2019). MSCs play an active and significant role in bone regeneration due to their ability to migrate to injured sites and differentiate into osteocytes. Additionally, MMPs are also involved in bone regeneration as it has been shown that inhibition of MMPs, in particular MMP-13, led to perturbations in the migration, proliferation and osteogenic differentiation capabilities of the MSCs (Kasper et al., 2007). It was further demonstrated in the same study that mechanical loading also played a role in regulating the expression of MMPs, which may be an important factor in regulating levels of MMPs to direct MSC osteogenic differentiation. The conditional ablation of MMP-14 from mouse dermal fibroblasts results in enhanced accumulation of collagen I in the ECM, resulting in a fibrotic skin condition associated with an increase in stiffness and tensile strength. This study suggested that MMP-14 contributes to collagen remodeling in adult skin, and plays a crucial role in maintaining dermal homeostasis (Zigrino et al., 2016). The migration of muscle stem cells (MuSCs) and progenitors to appropriate sites require physical interaction with its niche (Smith, et al., 2017). During this migration, cells experience mechanical resistance from the matrix, causing the cells to escape from their basement membrane. This process requires the expression of MMPs (MMP-1, MMP-14) from muscle progenitors to degrade the ECM in their path of migration (Wang et al., 2009; Xiaoping and Yong, 2009; Lund et al., 2014). Taken together, these studies show that MMPs play a critical role in modulating the physical properties of ECM to affect a variety of stem cell functions.

2.2 Cell‐substrate adhesions as niche factor

In multicellular organisms, adhesion molecules help to maintain tissue architecture, generate forces for cell movement and ensure the functionality of tissues by creating barriers (Vleminckx, 2017). Adhesion molecules bind to various ligands and receptors and the resulting signals are critical to many physiological processes such as cell growth, differentiation, contact inhibition and apoptosis (Vleminckx, 2017). The cytoplasmic domain of adhesion molecules bind indirectly to the cytoskeletal proteins such as actin and intermediate filaments, whereas their extracellular domain, via homophilic or heterophilic adhesion, interact with adhesion receptors on neighboring cells or ECM ligands. Furthermore, these adhesion molecules often cluster at specific restricted areas in the membrane, commonly termed as junctional complexes. The linkage to the cytoskeleton coupled with its clustering enhances the strength of adhesion forces nucleated by these adhesion molecules. Adhesion molecules are classified into five major groups based on their mode of interaction, function, structure and location. These groups are integrins, cadherins, selectins, proteoglycans and the immunoglobulin (Ig) superfamily (Samanta and Almo, 2015; Vleminckx, 2017). In this section, we will focus on the role of integrins, involved in cell-ECM interactions via the focal adhesions (FA) and cadherin, that mediate cell-cell interactions at the adherens junction (AJ) in stem cell functions. Junction complexes induced by cadherin and integrins can initiate signal transduction that facilitates niche signaling, in turn regulating stem cell properties such as self-renewal, proliferation and survival (Chen et al., 2013). The role of mechanical signals in regulating stem cell function, has been recently reviewed (Shih et al., 2011; Vining and Mooney, 2017; Naqvi and McNamara, 2020). However, the molecular mechanisms underpinning the mechanical activation of adhesion molecules and their roles in regulating stem cell fate are still less well understood.

2.2.1 Integrin

Integrins are transmembrane heterodimeric receptors consisting of α and β subunits that function as a mechanical link between the cellular cytoskeleton and the ECM (Figure 1) (Sun et al., 2016). The engagement of integrins with their extracellular ligands initiates intracellular biochemical responses (Hynes, 1992; Arnaout et al., 2007). In mammals, there are eight β-subunits and 18 α-subunits resulting in 24 distinct integrin receptors (Hynes, 2002). These receptors bind to different ECM ligands such as laminin, fibronectin and collagen IV, with specific heterodimers playing important roles in stem cell maintenance in different tissue niches. For example, α₂ integrin regulates the osteogenic differentiation in hMSCs and is upregulated in MSCs plated on stiffer matrices (42.1 kPa). On the other hand, the knockdown of α₂ integrin in these MSCs decreased osteogenic induction, suggesting a role for this integrin in mechanotransduction during osteogenic differentiation (Shih et al., 2011). The reduction in quiescence of neural stem cells (NSCs) is associated with a lower expression of β1 integrin, which, in turn, results in a reduced interaction of the β1 integrin on the NSCs to the laminin-rich microenvironment (Shen et al., 2008; Nascimento et al., 2018). On the other hand, bifunctional hydrogels with different stiffnesses (2 and 20 kPa) that are engineered with laminin peptide (IKVAV) and poly-lysine led to neurogenesis in embryonic cortical progenitors and adult NSCs respectively via β1 integrin. These data suggest that substrate stiffness and ligand specificity of integrin contribute to different stem cell behavior (Farrukh et al., 2017). Although integrin is a well-known mechanotransmitter, integrin-mediated mechanosensing in regulating the stem cell microenvironment is still being explored.

2.2.2 Integrin-associated proteins

Focal adhesions (FAs) are one of the key junctions involved in mechanosensing at the cell periphery. FAs comprise multimeric protein complexes which integrate both inside-out and outside-in signals and involve both mechanical and biochemical cues to regulate cellular functions (Vogel and Sheetz, 2006; Schiller and Fässler, 2013; Oakes and Gardel, 2014). FAs are nucleated by integrin receptors that form a mechanical link between the cytoskeleton and the ECM (Kanchanawong et al., 2010). Initially, integrins bind to the ligands found in the matrix, following which the cytoplasmic domain of the integrin subunit recruits multiple intracellular anchoring proteins such as talin, kindlin, paxillin, FAK, ILK, tensin etc (Figure 1). This anchorage can either result in the recruitment of vinculin, further linking this complex to the actin cytoskeleton, or result in direct engagement with the actin cytoskeleton (Alberts et al., 2002). Perturbations of these integrin-associated proteins have revealed their critical role in maintaining the stem cell niche.

Talin is an integrin-associated protein that is critical for integrin activation at the FA (Chinthalapudi et al., 2018). The lack of talin in embryonic stem cells in mice leads to the failure in the association of integrin with the cytoskeleton, resulting in embryonic lethality during gastrulation. This defect arises due to perturbed cell migration and cytoskeletal organization in the stem cell niche (Monkley et al., 2000). On the other hand, knockdown of talin in the testis results in disrupted adhesion within the germline stem cell (GSC) niche of Drosophila. This niche comprises stromal hub cells, GSCs and somatic cyst stem cells (CySCs). The adhesion between the hub cells and GSCs is required to maintain the undifferentiated state of GSCs, therefore the knock down of talin leads to an accumulation of differentiated GSCs (Raymond et al., 2009). A similar study in C. elegans showed that talin plays an important role in organizing the cytoskeleton, stabilizing adhesive contacts in muscle and modulating dynamic integrin signaling during migration (Cram et al., 2003).

Integrin-linked kinase (ILK) is a focal adhesion protein that interacts with the cytoplasmic tail of integrin β subunits and links them to the actin cytoskeleton. In the hair follicle stem cell (HFSC) niche, studies have pointed to the importance of ILK in maintaining quiescence of these cells. Deletion of ILK from the epidermis resulted in remodeling of the ECM and led to compensatory binding to laminin-511 over laminin-332 due to fragmentation and reduction of the latter. This imbalance caused an increase in Wnt and Tgf-β2 signaling and led to aberrant differentiation of HFSCs (Morgner et al., 2015). ILK has also been shown to be a key player during cardiomyogenesis. A decrease in ILK expression by siRNA resulted in a reduction in human fetal cardiomyogenesis, which could be attributed to an enhancement in Wnt signaling (Traister et al., 2012). Although the role of mechanotransduction in fetal cardiomyogenesis has not been directly investigated, it would be interesting to study if these dysregulations are mediated by forces generated by ILK. Lastly, mechanical stimulation of MSCs derived from mouse limb buds led to an increase in activation AKT/mTOR pathway which required ILK, ultimately resulting in an increase in differentiation and collagen expression in the niche of tendon cells (Mousavizadeh et al., 2020).

Focal Adhesion Kinase (FAK) is regulated by integrins and functions as a force sensor. Physically stretching cells causes cellular strain, increasing the force experienced at FAs, thereby activating FAK by phosphorylation at the Tyr397 residue (Schlaepfer et al., 1994; Calalb et al., 1995; Polte and Hanks, 1997). Forces experienced in focal adhesions are positively correlated with Tyr397 phosphorylated in FAK, suggesting that lower force results in reduced FAK activation (Torsoni et al., 2003). FAK activity is positively regulated by Rho-associated kinases and non-muscle myosin II. Cytoskeletal contractility along with FA formation decreased upon inhibition of the Rho-associated kinases (Seo et al., 2011). FAK activation is required for osteogenic differentiation (Salasznyk et al., 2007; Shih et al., 2011; Mathieu and Loboa, 2012) and is further correlated with myosin II being involved in osteogenic differentiation. Additionally, force-mediated activation of FAK results in activation of Rho which can then result in force-mediated adult stem cell differentiation (Thompson et al., 2012).

Tensin is known to interact with actin as well as integrins at the FAs and establishes a crucial connection between the cytoskeletal network and the ECM. Tensin three is widely expressed in tonsil-derived MSCs (TMSCs), where it plays an important role in the proliferation and differentiation of TMSCs by regulating the levels of β1-integrin (Park et al., 2019). The Ivaska’s group demonstrated the role of the energy sensor AMP-activated protein kinase (AMPK) that worked in association with tensin to increase the activity of integrins. Mechanistically, AMPK negatively regulates tensin 1 and tensin 3, which in the absence of AMPK, binds to β1-integrin, thereby regulating integrin dependent processes like cell adhesion, mechanotransduction and cell matrix formation (Georgiadou et al., 2017). Although not much is known about the role of tensin in mechanotransduction, future studies will be needed to address its role in stem cell homeostasis.

Kindlin is a scaffold protein, required for several protein-protein interactions in the FA complex. Recent studies have identified Kindlin 2 as a critical mechanosensor in MSCs. Kindlin 2 plays an important role in regulating YAP/TAZ expression and localization to regulate the fate of the MSCs. Mechanistically, kindlin-2 interacts with Myosin Light Chain Kinases (MLCKs), which controls the MSC microenvironment and intracellular signaling through RhoA activation and phosphorylation of MLC. This interaction controls the actin organization and YAP/TAZ phosphorylation, ultimately controlling YAP/TAZ mediated gene expression to regulate the MSC differentiation (Guo et al., 2018). Kindlin-2 is also reported to regulate chondrogenesis, osteogenesis and osteocyte survival. Deleting kindlin-2 from osteocytes, which are the mechanosensors of bone, has been shown to impair bone homeostasis, disrupt FA formation, cytoskeletal organization and cell orientation in bone. Loss of kindlin 2 also induced apoptosis in osteocytes and resulted in the abnormal expression of sclerostin, a negative regulator of bone formation under mechanical stimulation (Qin et al., 2021).

Paxillin is a phosphotyrosine-containing docking protein that is primarily localized to the FA complex (Glenney and Zokas, 1989; Schaller, 2001). Paxillin interacts with FAK and other signaling molecules, associated with integrin signaling and membrane trafficking (Wade et al., 2002). The mechanosensing properties of paxillin are enabled by its binding to activated vinculin that stabilizes the FA-cytoskeleton interaction. Both paxillin null mouse embryonic stem (ES) cells and paxillin null differentiated cells display defects in focal adhesion and cell spreading, coupled with an observed reduction in FAK phosphorylation (Wade et al., 2002). As studies have only begun to scratch the surface, research demonstrating a direct link between mechanotransduction and maintenance of the stem cell niche via paxillin requires further investigation.

The FA protein vinculin, which is associated with the actin cytoskeleton, is also present at the cell-cell junction (AJ). Vinculin is a well-known mechanotransducer that directly interacts with talin, α-actinin and paxillin at the FAs and α-catenin at the AJs. Various studies have shown the mechanotransduction role of vinculin at the cellular level. Only a few studies have highlighted the mechanotransduction role of vinculin in maintaining the SC niche. A study by Holle et al. showed that KD of vinculin in hMSCs resulted in a reduction of cytoplasmic and FA vinculin (Holle et al., 2013). Vinculin KD also led to a reduction in myoblast determination protein 1 (MyoD) expression in the nucleus. MyoD is the transcription factor which induces stem cell differentiation into a myoblast lineage. Re-expression of the full length or head domain of vinculin was sufficient to restore MyoD expression allowing cells to return to their myogenic state. Additionally, vinculin KD cells displayed hampered durotaxis or cell migration towards a stiffer, more myogenic-permissive matrix as opposed to control cells, which assembled preferentially at the myogenic-permissive matrix. Another transcription factor, Myogenic factor 5 (Myf5), regulates muscle differentiation along with MyoD. Studies have shown that vinculin KD resulted in the loss of stiffness-mediated expression of MyoD and Myf5 hindering myogenic differentiation. Recently, our group has shown the role of vinculin in maintaining HFSC quiescence (Biswas et al., 2021). Usually HFSCs are maintained in a quiescence state which is achieved by the cell to cell contact mediated inhibition of proliferation (Fan and Meyer, 2021). Conditional KO of vinculin in murine epidermis resulted in mechanically weak AJs which failed to sequester YAP at the junctions and led to increased proliferation of the HFSCs. Mechanistically, our work showed that, in contact-inhibited (quiescent) bulge stem cells, vinculin was critical in maintaining α-catenin in a stretched/open conformation reinforcing the junction which in turn kept YAP sequestered at the AJs. These studies highlight the crucial role of mechanotransduction through vinculin at the FAs and AJs for maintaining the SCs niche.

2.3 Cell-cell adhesions as niche factor

So far, we have discussed how integrins and integrin associated proteins at the FAs play an active role in mechanotransduction. Cells also interact with each other by forming cell-cell junctions including AJs, desmosomes, tight junctions and gap junctions (Figure 1). Among these, AJs are the key adhesion structures that interact with the cytoskeleton of neighboring cells to enable mechanical force transduction (Pannekoek et al., 2019).

2.3.1 Adherens junction

AJs mediate adhesion through homotypic interactions of cadherins such as E-cadherin which are calcium-dependent, transmembrane proteins (Figure 1). E-cadherin associates with the catenin family of proteins such as β-catenin, α-catenin, and p120 via its cytoplasmic domain. This forms an E-cadherin-catenin complex that interacts with the F-actin cytoskeleton by either direct binding to α-catenin or an indirect association via vinculin (Koirala et al., 2021). AJs regulate cell-cell adhesion within the stem cell niche thereby affecting stem cell fate.

2.3.1.1 E-cadherin

E-cadherins are critical to the formation and maintenance of cell junctions, and for the proliferation, survival and differentiation of cells to maintain tissue integrity. Cell-cell adhesion mediated by E-cadherin is linked to signaling pathways that transduce signals to the cytoplasm and nucleus (Stepniak et al., 2009). Studies have also shed light on the importance of E-cadherin mediated stem cell niche maintenance in regulating the self-renewal of NSCs (Karpowicz et al., 2009). E-cadherin has also been shown to be crucial in maintaining the pluripotency of mESCs as the disruption in E-cadherin leads to increased Epithelial-Mesenchymal Transition (EMT) and differentiation of these cells (Redmer et al., 2011). The deletion of the E-cadherin gene in mESCs leads to the failure of cell compaction in the embryonic blastocyst that is important for maintaining the epithelial subcellular structures i.e., cellular junctions, during early mammalian development (Larue et al., 1994). Additionally, E-cadherin induces conformational changes in α-catenin through the transmission of adhesion forces from the cell-cell junctions. This leads to strengthened binding of α-catenin to F-actin and the recruitment of vinculin to the site where these forces are applied.

2.3.1.2 β-catenin

In epithelial tissue, β-catenin is one of the crucial components of the AJ, where it links cadherins to the cytoskeleton of the cell, thus establishing cell adhesion. Subcellular localization of β-catenin is known to determine its function within the cell (Dietrich et al., 2002). When β-catenin localizes in the cytoplasm or nucleus, it functions as a major signaling hub for the Wnt/β-catenin signaling pathway, where it acts as a transcriptional co-activator of T cell factor/lymphoid enhancer factor family (TCF/LEF) target genes (Kim et al., 2019). β-Catenin also acts as a mechanotransducer (Benham-Pyle et al., 2016), where mechanical cues induce its nuclear accumulation and enhance transcriptional activity (Benham-Pyle et al., 2015). Additionally, it has also been reported that mechanical perturbation of Drosophila embryos causes increased β-catenin signaling and upregulation of its downstream target genes (Farge, 2003). The Wnt/β-catenin signaling pathway is known to respond to ECM stiffness (Du et al., 2016), which ultimately affects cellular functions such as proliferation, differentiation, migration, genetic stability, apoptosis, and stem cell renewal (Pai et al., 2017).

Jansen and co-workers demonstrated that the biphasic effects of mechanical loading on β-catenin resulted in negative effects on Wnt signaling in osteoblast differentiation and mineralization (Jansen et al., 2010). Murine embryonic stem cells (mESCs) showed enhanced expression of various pluripotency markers Oct4, Sox2, Nanog, LIF (also known as mechanopluripotency) when cultured in a stirred suspension bioreactor. Mechanical cues promoted by fluid shear induces the nuclear translocation of β-catenin. This causes a concomitant increase of c-Myc, which is an upstream regulator of these pluripotency markers, ultimately promoting mESCs mechanopluripotency (Nath et al., 2021). This study indicates that mechanotransduction through the AJ complex is critical for mESC pluripotency maintenance. In inner ear progenitor cells (IEPCs), external mechanical signals from ECM can be transduced through the RhoA-YAP-β-catenin signaling cascade to regulate its survival, proliferation and differentiation (Xia et al., 2020). Taken together, β-catenin functions as a mechanical regulator that controls cellular functions important for maintaining stem cell homeostasis.

2.3.1.3 α-catenin

α-Catenin is another key molecule in the AJ, that links to the actin cytoskeleton and the cadherin complex via β-catenin (Niessen & Gottardi, 2008). The association of α-catenin with the actin cytoskeleton, allows it to sense the changes in tissue tension during cytoskeletal contraction. α-Catenin thus acts as a mechanosensor, where it converts mechanical cues into biochemical signals that control cell proliferation and cell death (Yonemura et al., 2010; Sarpal et al., 2019). The Conditional KO of α-catenin in the skin epidermis results in abnormal hair morphogenesis, along with defective AJ formation and cell polarity (Vasioukhin et al., 2001). Additionally, the loss of α-catenin from the epidermis results in hyperproliferation of the interfollicular epidermis (IFE) and the presence of multinucleated cells. This, in turn, leads to a precancerous skin condition with characteristics similar to squamous cell carcinoma. A follow-up study by Vasioukhin’s group in 2011 showed that specific deletion of α-catenin from the HFSC compartment led to the development of squamous cell carcinomas. This was due to the direct interaction of the transcriptional co-activator YAP1 with α-catenin. The cKO of α-catenin from the HFSC leads to translocation of YAP to the nucleus, thereby promoting cell proliferation and forming pre-cancerous lesions (Silvis et al., 2011). It was later demonstrated that the interaction of 14-3-3 and the PP2A phosphatase with α-catenin led to the phosphorylation of YAP1, sequestering it to the junctions, and preventing hyperproliferation (Schlegelmilch et al., 2011). This suggested that α-catenin acts not only as a tumor-suppressor, but also as a sensor of cell density in the skin. Knockdown of α-catenin in human embryonic SCs (hESCs) results in the induction of endodermal differentiation due to ubiquitylation and proteolysis of β-catenin. This inhibits repression of Wnt target genes in the transformed cells (Choi et al., 2013). Association of α-catenin with the adenomatous polyposis coli (APC) tumor suppressor, a component of the Wnt/β-catenin pathway, was shown to control the ubiquitination of β-catenin via the APC destruction complex. Therefore, the reduction of α-catenin levels in hESCs leads to a failure in proteolytic destruction of β-catenin, inducing differentiation of the endoderm. Studies on the process of mechano-sensing of α-catenin have only recently started to be investigated. However, the force-dependent conformational change of α-catenin has been shown to activate proteins that facilitate binding with the dynamic actin cytoskeletal network.

2.3.1.4 p120

p120 catenin is one of the catenins that interacts with E-cadherin at the AJ (Reynolds et al., 1994; Kourtidis et al., 2013). The localization of p120 catenin from the AJ to the cytoplasm upon mechanical stress sensing results in the increased turnover of E-cadherin, which in turn promotes wing development in Drosophila, suggesting the importance of p120 as a mechanotransducer at the junctions (Iyer et al., 2019). Several other studies have also described the role of p120 in SC maintenance. During early embryogenesis in mice, p120 null mutant mouse embryonic SCs (mESCs) failed to differentiate completely. The absence of p120 in mESCs leads to the destabilization of E-cadherin at the AJs, causing defective formation of the primitive endoderm (Pieters et al., 2016). A study on mESCs by Pierre D. McCrea’s group showed that p120 catenin negatively regulates a repressive transcriptional complex, RE1-silencing transcription factor/co-repressor (REST/coREST), that plays a critical role in stem cell fate determination. Direct binding of p120 to the REST/coREST complex prevented proper differentiation of the mESCs towards neural fate, thereby uncovering a role for p120 in modulating SC differentiation (Lee et al., 2014). p120 catenin acts as a mediator in cellular positioning and organ patterning during fate determination of pancreatic progenitors in mice by regulating the differential expression of E-cadherin. This in turn drives cellular motility and directs cells towards specific niches to determine their cellular fate (Nyeng et al., 2019). Taken together, p120 not only acts as a mediator for E-cadherin function but also plays an important role in lineage commitment. Further studies are required to fully understand how mechanotransduction by p120 regulates the SC niche.

2.3.2 Desmosomes

Desmosomes are intercellular cadherin-mediated cell-cell junctions that couples to the intermediate filaments and confer mechanical stability when cells are exposed to tensile and mechanical stress (Figure 1). Specifically, desmosomal cadherins are formed by desmogleins 1-4 and desmocollin 1–3, which bind to armadillo proteins plakoglobin and plakophilins via their cytoplasmic tails and subsequently binds to intermediate filaments via Desmoplakin (Angulo-Urarte et al., 2020). The KO of DSG2 results in peri-implantation lethality and also led to a decrease in embryonic stem cell proliferation (Eshkind et al., 2002). DSG2 was shown to be important for regulating the self-renewal and differentiation capacity of pluripotent stem cells (PSCs). Depletion of DSG2 using monoclonal antibodies in hPSCs resulted in decreased proliferation and reduced expression of pluripotency markers (Park et al., 2018). These results implicate a role of desmosomes in regulating stem cell proliferation and differentiation, however, more work is needed to ascertain how mechanical signals regulate this process. Different compositions of desmosomes lead to a difference in the strength of cell-cell adhesion in different layers of the skin, which in turn, correlates with different levels of proliferation and differentiation. The basal proliferating keratinocytes express desmocollin 2/3 (DSC2/3) and desmoglobin 2/3 (DSG2/3) which displayed the weakest binding out of all the different desmosomal proteins. In contrast, the differentiated cells in the suprabasal layers such as the cornified layer contain a higher composition of DSC1 and DSG1/4, which provided the strongest binding strength. This correlates with the need for differentiated keratinocytes to form strong and stable cell-cell adhesions to maintain a physical barrier that protects the epidermis from mechanical and chemical stresses (Harrison et al., 2016; Green et al., 2019). Taken together, studies on desmosomes have begun to shed some light in understanding its role along with other adhesion proteins in maintaining the proliferative capacity of stem cells in its niche. However, more studies are needed to fully understand its role in mechanical transduction and maintaining other stem cell niches.

2.3.3 Tight junctions

Tight junction (TJ) proteins are a branching network of intercellular adhesion complexes that controls the permeability of the tissue. TJs are present on epithelial and endothelial cells (Figure 1). In the epithelium, tight junction structures form partitions between the apical and the basolateral domains that prevent the intermixing of both the transmembrane components, thereby supporting cell polarity. TJ proteins are categorized into two groups depending on their functionality: integral transmembrane protein and peripheral membrane proteins or plaque proteins. Four transmembrane proteins namely claudins, occludin, tricellulin and junctional adhesion molecule (JAM) aids in forming tightly regulated networks between the peripheral membrane proteins. On the other hand, peripheral adapter proteins such as zona-occludens 1 (ZO-1), ZO-2 and ZO-3 play a role in connecting the transmembrane proteins to the cytoskeleton and other signaling molecules (Lee et al., 2018). Differences in expression of these TJ proteins play an important role in regulating the barrier integrity of the membrane.

Studies have shown that TJ proteins play an important role in controlling the biological functions of several stem cells. For example, occluding junctions have been shown to play a novel role in regulating the niche of the hematopoietic stem cells when induced with a bacterial infection (Khadilkar et al., 2017). In Drosophila, an immune response is triggered upon infection that leads to barrier breaks due to modulations in the occluding junctions. This in turn helps in prohemocyte differentiation that eventually induced immune cell production, thereby activating the immune response. TJ proteins like occludins, ZO-1, caludins present in human NSCs (hNSCs) are known to help in the formation of hNSC clusters known as neurospheres. The formation of these neurospheres are critical for maintaining the stemness of hNSCs. TJ proteins were downregulated upon induction of differentiation in NSCs, further corroborating the fact that they are important in maintaining the stemness of the NSCs (Watters et al., 2015). This suggests a plausible connection between TJ protein levels and their regulation of the NSC niche. However, further studies are required to establish the direct interaction of NSCs and the TJ protein complex that might play a role in this cluster formation.

3 Implication of adhesion molecules in diseases

Several diseases have been linked to changes in the expression or function of various adhesion molecules (Table 1).

3.1 Inflammatory bowel disease

One of the roles of the intestinal epithelium is to prevent the exposure of the gastrointestinal tract to foreign antigens and harmful microbiota. This is achieved by the formation of tightly regulated cell junctions and organization of the epithelium to establish a barrier. This epithelial barrier integrity is maintained by the TJ proteins that consist of both transmembrane and peripheral membrane proteins like occludin, zonula occludens and claudins that are linked to the cytoskeleton of the cell (Landy et al., 2016; Chelakkot et al., 2018). Defects in maintaining this barrier function leads to pathological conditions like inflammatory bowel disease (IBD).

IBD is a chronic inflammatory disease that causes severe inflammation of the gastrointestinal tract. The disease is mainly categorized into two types depending on the part of the inflamed intestine: Ulcerative colitis (UC) and Crohn’s disease (CD) (Chelakkot et al., 2018; Binienda et al., 2020). The characteristic symptoms of IBD are a leaky gut that is caused by the apoptotic and ulcerative intestinal epithelium, resulting in severe inflammation. Previous studies have shown that over-expression of a TJ protein claudin 2 in UC patients increased pore formation in their epithelium. On the other hand, claudins 3, 4 and 7 which help in tightening the epithelial junctions were found to be reduced in these patients (Prasad et al., 2005; Oshima et al., 2008). This suggested differential expression of several TJ proteins might be a major cause of increased permeability of the intestinal epithelium that leads to defective barrier function. Similarly, in CD, perturbed organization of the TJ proteins was observed in inflamed areas. Several studies showed claudin 2 to also be upregulated in the CD patients with a concomitant downregulation of claudin 3,5,8 (Kucharzik et al., 2001; Zeissig et al., 2007; Das et al., 2012). In addition to TJ proteins, AJ proteins have also been shown to be involved in a relapse of this disease. Downregulation of the E-cadherin-catenin complex led to the loss of cell-cell junctions in the gut that exposed the luminal content to the immune cells thereby increasing the relapse of CD (Wyatt et al., 1993; Arnott et al., 2000).

Treatment options for IBD have substantially improved over the past few decades. Several drugs have been developed to target interleukins (ILs), tumor necrosis factor (TNF) as well as JAK signaling that regulates several cytokines, for treating both the types of IBD. Even though there has been advancement in the drug discovery and delivery process, some patients still do not respond to the drugs and display a relapse of the symptoms. SC based therapy is a promising treatment option that has started to develop. Somatic SCs such as HSCs and MSCs have already been used for treating IBD patients (Shimizu et al., 2019). The HSC transplantation process requires rebooting the immune system by lymph ablation followed by reconstruction of the immune system. A pilot study based on autologous HSC transplantation showed regaining of responsiveness to the drugs as well as sustained remission in about 80% of the patients suffering from refractory CD (López-García et al., 2017). Even though there was an improvement after the transplantation, CD relapsed in most of the patients in a span of 5 years. In addition, severe adverse events occurred in many patients who received HSCT compared to the control group. Taken together, this study suggested HSCT to be one of the methods that can be used for treating patients with severe CD but requires improvement compared to the conventional methods.

Mesenchymal stem cell therapy is another technique that has been used for treating active CD fistula (Misselwitz et al., 2020). MSCs have been reported to show immunosuppressive behavior as well as decreased the effect of the lymphocytes, thereby modulating the immune system (Aggarwal and Pittenger, 2005; Corcione et al., 2006; Ren et al., 2008). Clinical studies have already been conducted using bone marrow derived MSC transplantation (MSCT) as well as adipose derived MSC transplantation (ASCT) (Shimizu et al., 2019). In a phase 2 trial of allogeneic mesenchymal stromal cell transplantation, the Crohn’s disease activity index (CDAI) was reduced in patients suffering from luminal CD (Forbes et al., 2014). Almost 53% of the patients had clinical remission within 42 days of receiving the treatment. In this study, only one case of severe adverse effect was reported, which led to the occurrence of stage 1 adenocarcinoma after 3 weeks of the treatment. Even though MSCT seemed better than the HSCT, long term efficacy of this treatment to maintain long-term disease remission needs further investigation. On the other hand, in a phase 3 randomized, double-blind study, ASCT was shown to be an effective treatment for patients with complex perianal fistula associated with Crohn’s disease (Panés et al., 2016). Among the 212 patients randomly divided into treatment and placebo groups, almost 50% of the ASCT treated patients attained remission. Adverse effect cases that included anal abscess and proctalgia were almost similar in number for both the treated and placebo patients. This suggested both ASCT and MSCT to be safer treatment options for IBD patients who failed to respond to conventional treatments.

In 2012, Yui et al. developed intestinal organoid models and transplanted intestinal stem cells (ISC) in mice with colitis (Yui et al., 2012). Based on this study, Ryuichi Okamoto’s group is now using ISC transplantation (ISCT) to study this potential treatment method to cure patients with refractory IBD. ISCs have been isolated from patient derived biopsies that are now being tested for therapeutic potential (Shimizu et al., 2019). These cells have the potential to proliferate and reestablish the wound bed in these patients, thereby protecting the organ from mechanical and pathogenic insults. This method is awaiting clinical trials but has the potential to directly cause mucosal healing. In addition to the stem cell-based treatments, given the importance of maintaining barrier function in IBD, identifying the mechanism of the cell-cell junctions regulation might aid in improving these therapeutics.

3.2 Epidermolysis bullosa

Epidermolysis bullosa (EB) is a group of rare diseases caused by mutations in genes that encode for both ECM and focal adhesion proteins and is estimated to affect 1 in 30,000 people worldwide (Bruckner et al., 2020). It is characterized by fragile skin and severe blistering and lesions that can occur from as early as childbirth. The most common type of EB is Epidermolysis Bullosa Simplex (EBS), and can be caused by autosomal recessive mutation of the desmoplakin gene in the suprabasal cells or autosomal dominant mutations in the keratin 5/14 genes in the basal cells. Junctional Epidermolysis Bullosa (JEB), which occurs due to an autosomal recessive mutation in an array of ECM and hemidesmosome proteins such as Laminin-332 and α6β4 and BP230 integrin along the basement membrane. Dystrophic Epidermolysis Bullosa (DEB) occurs due to a mutation in Collagen VII, which is localized below the basement membrane (Bruckner-Tuderman, 2019). These molecular mutations impair the structure and functional integrity within highly specialized interfaces of the skin, that are important for cell adhesion, tissue repair and barrier function. Ultimately, this leads to a diminished resistance to mechanical stress and shearing forces, which causes subsequent cell and tissue damage (Uitto and Richard, 2004; Fine et al., 2008; Bruckner-Tuderman et al., 2013).

EB poses as a potentially life-threatening disease as the perpetual and progressive scarring triggered by skin blistering and lesions leads to chronic wounds. These chronic wounds are coupled with increased bacterial colonization, fibrosis, inflammation, and a systemic development of cutaneous squamous cell carcinoma (Guerra et al., 2017). Mutations in the genes are not restricted to the skin but also in other epithelialized (gastrointestinal, urogenital tract, respiratory) or mesenchymal (skeletal muscle) organs (Prodinger et al., 2019). EB with Pyloric atresia in patients affects both the skin and digestive tract, causing severe blistering and also an obstruction of the pylorus (Nakano et al., 2001). There are no direct cures for any of the EB subtypes, and current treatment strategies are only useful in managing the wounds and pain caused by EB. Numerous preclinical research and developments using gene correction, protein replacement and cell-based treatments such as bone marrow transplantation and mesenchymal stem cell therapy have pointed to new therapeutic avenues and have entered early clinical trials.

Stem cells present a promising avenue to reverse some of the damage caused by Recessive Dystrophic Epidermolysis Bullosa (RDEB) and early research in animal models suggest that hematopoietic cell transplantation (HCT) from WT donor-derived cells to RDEB mice improved its survival and skin strength (Tolar et al., 2009). These positive results spurred the development of a small clinical trial involving allogeneic HCT in 6 children with RDEB. Overall, the trial showed promising results as 5 out of 6 of the patients displayed an increase in collagen VII deposition in the Dermal Epidermal Junction (DEJ), improved wounding healing and a decrease in blister formation (Tolar and Wagner, 2013). Additional trials have been conducted with varying outcomes (Petrof et al., 2015; Rashidghamat and McGrath, 2017). Current phase 2 clinical trials include further testing of healthy donor mesenchymal stem cell infusions into EB patients. These developments are promising and provide potentially better therapeutic treatments forEB. (https://clinicaltrials.gov/ct2/show/NCT02582775; https://clinicaltrials.gov/ct2/show/NCT01033552). Additionally, studies from other groups have successfully employed ex vivo cell and gene therapy to treat intermediate JEB caused by mutations in Laminin β3. In an initial study, epidermal stem cells from an adult patient affected by Laminin β3 deficient JEB were transduced with a retroviral vector expressing Laminin β3 cDNA encoding functional Laminin β3 and applied to the affected skin area as cohesive epidermal sheets made from a plastic substrate (Mavilio et al., 2006). The study proved to be efficacious during a 6.5 years follow up, where the epidermis became fully functional and restored with no adverse reaction (De Rosa et al., 2014). This positive response spurred further testing on a 7-year-old boy in 2015 with EB and epidermal loss in 80% of his body using the same gene therapy to produce functional laminin 332 from transgenic cultured epidermis using a fibrin substrate (Hirsch et al., 2017). Similarly, the patient displayed good results after the treatment, with his newly formed epidermis expressing normal levels of laminin 332, displaying a functional basement membrane that remained resistant to mechanical stress and blistering. In the long run, gene therapy to correct mutations causing EB might prove useful. Further scrutiny and hopes can be pinned onto these 2 patients as they continue to undergo observational studies to monitor the efficacy of this treatment method (https://clinicaltrials.gov/ct2/show/NCT05111600).

3.3 Breast cancer

Breast cancer is the most common cancer occurring in women globally. Annually, about 1.7 million new cases are recorded in the world (Hai-Ying et al., 2020). The mammary gland is the milk-producing organ in animals, which continuously develops after birth and fully differentiates upon pregnancy and lactation. During postnatal development and onset of reproductive cycles, the mammary gland is dynamically remodeled and undergoes morphological changes due to changes in cell proliferation, differentiation, migration and apoptosis. This inherent plasticity has been suggested to increase the susceptibility of the organ to carcinogenesis (Paavolainen and Peuhu, 2021).

Mechanical signals that cells receive from their surroundings are emerging as key players and contributors to tumor progression (Humphrey et al., 2014; Panciera et al., 2017). These mechanical signals change with the composition of the ECM during mammary development. Tumor progression of mammary cells can be characterized by increased ECM deposition, also known as desmoplasia. Collagen V is increased in desmoplastic stroma in human breast carcinoma (Barsky et al., 1982). Clinically, desmoplastic stroma is associated with a 4–6 fold increased relative risk of developing breast carcinoma, with poor prognosis (Boyd et al., 2001; Guo et al., 2001).

Recent studies have begun to highlight the importance of external mechanical signals that mammary gland cells receive in driving tumorigenesis. Initially, it was shown that primary luminal mammary gland cells were able to form self-renewing colonies in the presence of oncogenic factors such as EGFR and activated HER2 (Panciera et al., 2020). This led to the development of solid organoids composed entirely of K8+ luminal cells which are a hallmark of human HER2+ breast cancer. However, when these cells were plated on a soft adhesive hydrogel of 0.5 kPa which phenocopies the external environment of the normal mammary gland, the presence of the same oncogenic factors were insufficient to develop into self-renewing solid organoids reminiscent in breast cancers. However, when the primary luminal cells were plated on the hydrogels of higher rigidity (40 kPa), the growth of these organoids was observed. Mechanistically, this was shown to be due to the mechanical cues conferred from a stiffer environment, that ultimately led to increased YAP/TAZ signaling and increased proliferation and self-renewal (Panciera et al., 2020). YAP activation also causes remodeling of the surrounding ECM and this favored tumor spreading (Calvo et al., 2013).

Other studies have also begun to highlight the role of various cell adhesion molecules in the development of breast cancer, such as the activation of intracellular FAK (dos Santos et al., 2012; Provenzano and Keely, 2009). In particular, change to a stiffer ECM has been found to correlate with increased FAK activation and increase tumorigenesis in mammary cells. Integrin αvβ3 was also found to be significantly elevated in metastatic tumors compared to primary pancreatic and breast tumors. Mechanistically, this seemed to occur by the recruitment of Src kinase that promotes migration of the cancer cells (Ghajar & Bissell, 2008; Desgrosellier et al., 2010). Studies from multiple groups have described potential therapeutic modalities such as integrin β1 blocking antibodies, since tumors derived from human xenograft models and transgenic models displayed significant growth inhibition upon treatment with an integrin β1 inhibitory antibody (White et al., 2004; Park et al., 2006). As the ECM is increasingly recognized as the master regulator of cell response and behavior, an increase in the knowledge and understanding of the dynamic role that ECM plays in cancer biology, both in terms of its architectural complexity and how this affects the tumor progression in breast cancer, will be valuable. Biomimetic models such as the decellularized ECM recapitulates the complex ECM microenvironment of the mammary glands and can be useful tools to allow a better understanding of cell-ECM interactions. Although these approaches to treating breast cancer are still new, it may shed light on the tumorigenesis of the mammary gland cancer and open new treatment paradigms (Wishart et al., 2020; Tamayo-Angorrilla et al., 2021).

4 Discussion, perspectives and future directions

The connection between cells and ECM through FA and the cell to cell junction through AJ, both serve as mechanosensitive hubs. In this review, we have discussed how mechanotransduction through these hubs contribute to maintaining various stem cell niches. Additionally, we have discussed upcoming stem cell-based therapeutics for several diseases which are associated with the adhesion molecules. Another major player involved in the mechanotransduction process is the nucleus and the nuclear envelope (NE), which is gaining importance as mechanosensory organelles. The Linker of Nucleoskeleton and Cytoskeleton (LINC) complexes at the NE, serves as mechanosensory hubs which connects between various cytoskeletal components of the cell (actin, microtubules and intermediate filaments) and nucleoskeletal system of the nucleus (lamins). Specifically, mutations in the lamin A, which is present at the inner nuclear membrane results in various laminopathies such as progeria (Gotzmann and Foisner, 2006), and muscular dystrophies which affects the functions of stem cell pools such as MSCs and muscle stem cells respectively (Favreau et al., 2004; Frock et al., 2006).

While several studies have highlighted the importance of these molecules and their involvement in a plethora of human diseases, there are very few studies that directly correlate mechanical signaling and disease progression. It is therefore crucial to bridge this gap in order to identify new therapeutic interventions that will increase clinical success in treating these diseases. The role of mechanotransduction in the field of regenerative medicine is starting to gain importance. Beyond regenerative medicine, the implication of microenvironmental factors that regulates both mechanical and biochemical signaling to improve the disease outcome remains largely unexplored and opens up an exciting domain of research.

References

• 1

  AaronB. B.GoslineJ. M. (1981). Elastin as a random-network elastomer: A mechanical and optical analysis of single elastin fibers. Biopolymers20, 1247–1260. 10.1002/bip.1981.360200611

  • CrossRef
  • Google Scholar

• 2

  AdamsJ. C.Chiquet-EhrismannR.TuckerR. P. (2015). The evolution of tenascins and fibronectin. Cell. adh. Migr.9, 22–33. 10.4161/19336918.2014.970030

  • CrossRef
  • Google Scholar

• 3

  AffolterA.LammertA.KernJ.ScherlC.RotterN. (2021). Precision medicine gains momentum: Novel 3D models and stem cell-based approaches in head and neck cancer. Front. Cell. Dev. Biol.9, 666515. 10.3389/fcell.2021.666515

  • CrossRef
  • Google Scholar

• 4

  AggarwalS.PittengerM. F. (2005). Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood105, 1815–1822. 10.1182/blood-2004-04-1559

  • CrossRef
  • Google Scholar

• 5

  AkhirH. M.TeohP. L. (2020). Collagen type I promotes osteogenic differentiation of amniotic membrane-derived mesenchymal stromal cells in basal and induction media. Biosci. Rep.40, BSR20201325. 10.1042/BSR20201325

  • CrossRef
  • Google Scholar

• 6

  AkhmanovaM.OsidakE.DomogatskyS.RodinS.DomogatskayaA. (2015). Physical, spatial, and molecular aspects of extracellular matrix of in vivo niches and artificial scaffolds relevant to stem cells research. Stem Cells Int., 167025. 10.1155/2015/167025

  • CrossRef
  • Google Scholar

• 7

  AlbertsB.JohnsonA.LewisJ. (2002). “Molecular biology of the cell,” in The self-assembly and dynamic structure of cytoskeletal filaments. 4th edition (New York: Garland Science).

  • Google Scholar

• 8

  Angulo-UrarteA.van der WalT.HuveneersS. (2020). Cell-cell junctions as sensors and transducers of mechanical forces. Biochim. Biophys. Acta. Biomembr.1862, 183316. 10.1016/j.bbamem.2020.183316

  • CrossRef
  • Google Scholar

• 9

  ArjmandB.SarvariM.Alavi-MoghadamS.PayabM.GoodarziP.GilanyK.et al (2020). Prospect of stem cell therapy and regenerative medicine in osteoporosis. Front. Endocrinol.11, 430. 10.3389/fendo.2020.00430

  • CrossRef
  • Google Scholar

• 10

  ArmonyG.JacobE.MoranT.LevinY.MehlmanT.LevyY.et al (2016). Cross-linking reveals laminin coiled-coil architecture. Proc. Natl. Acad. Sci. U. S. A.113, 13384–13389. 10.1073/pnas.1608424113

  • CrossRef
  • Google Scholar

• 11

  ArnaoutM. A.GoodmanS. L.XiongJ. P. (2007). Structure and mechanics of integrin-based cell adhesion. Curr. Opin. Cell. Biol.19, 495–507. 10.1016/j.ceb.2007.08.002

  • CrossRef
  • Google Scholar

• 12

  ArnottI. D. R.KingstoneK.GhoshS. (2000). Abnormal intestinal permeability predicts relapse in inactive Crohn disease. Scand. J. Gastroenterol.35, 1163–1169. 10.1080/003655200750056637

  • CrossRef
  • Google Scholar

• 13

  ArulmoliJ.PathakM. M.McDonnellL. P.NourseJ. L.TombolaF.EarthmanJ. C.et al (2015). Static stretch affects neural stem cell differentiation in an extracellular matrix-dependent manner. Sci. Rep.5, 8499. 10.1038/srep08499

  • CrossRef
  • Google Scholar

• 14

  AumailleyM.Bruckner-TudermanL.CarterW. G.DeutzmannR.EdgarD.EkblomP.et al (2005). A simplified laminin nomenclature. Matrix Biol.24, 326–332. 10.1016/j.matbio.2005.05.006

  • CrossRef
  • Google Scholar

• 15

  BaniebrahimiG.MirF.KhanmohammadiR. (2020). Cancer stem cells and oral cancer: Insights into molecular mechanisms and therapeutic approaches. Cancer Cell. Int.20, 113. 10.1186/s12935-020-01192-0

  • CrossRef
  • Google Scholar

• 16

  Barraza-FloresP.HermannH. J.BatesC. R.AllenT. G.GrunertT. T.BurkinD. J. (2020). Human laminin-111 and laminin-211 protein therapy prevents muscle disease progression in an immunodeficient mouse model of LAMA2-CMD. Skelet. Muscle10, 18. 10.1186/s13395-020-00235-4

  • CrossRef
  • Google Scholar

• 17

  BarskyS. H.RaoC. N.GrotendorstG. R.LiottaL. A. (1982). Increased content of type V collagen in desmoplasia of human breast carcinoma. Am. J. Pathology.

  • Google Scholar

• 18

  BeckK.HunterI.EngelJ. (1990). Structure and function of laminin: Anatomy of a multidomain glycoprotein. FASEB J.4, 148–160. 10.1096/fasebj.4.2.2404817

  • CrossRef
  • Google Scholar

• 19

  Benham-PyleB. W.PruittB. L.NelsonW. J. (2015). Cell adhesion. Mechanical strain induces E-cadherin-dependent Yap1 and β-catenin activation to drive cell cycle entry. Science348, 1024–1027. 10.1126/science.aaa4559

  • CrossRef
  • Google Scholar

• 20

  Benham-PyleB. W.SimJ. Y.HartK. C.PruittB. L.NelsonW. J. (2016). Increasing β-catenin/Wnt3A activity levels drive mechanical strain-induced cell cycle progression through mitosis. ELife5, e19799. 10.7554/eLife.19799

  • CrossRef
  • Google Scholar

• 21

  BenoitY. D.GroulxJ.-F.GagnéD.BeaulieuJ.-F. (2012). RGD-dependent epithelial cell-matrix interactions in the human intestinal crypt. J. Signal Transduct., 248759. 10.1155/2012/248759

  • CrossRef
  • Google Scholar

• 22

  BiniendaA.ZiolkowskaS.HaugeI. H.SalagaM. (2020). The role of immune and epithelial stem cells in inflammatory bowel disease therapy. Curr. Drug Targets21, 1405–1416. 10.2174/1389450121666200504074922

  • CrossRef
  • Google Scholar

• 23

  BiswasR.BanerjeeA.LemboS.ZhaoZ.LakshmananV.LimR.et al (2021). Mechanical instability of adherens junctions overrides intrinsic quiescence of hair follicle stem cells. Dev. Cell.56, 761–780.e7. 10.1016/j.devcel.2021.02.020

  • CrossRef
  • Google Scholar

• 24

  BoydN. F.MartinL. J.StoneJ.GreenbergC.MinkinS.YaffeM. J. (2001). Mammographic densities as a marker of human breast cancer risk and their use in chemoprevention. Curr. Oncol. Rep.3, 314–321. 10.1007/s11912-001-0083-7

  • CrossRef
  • Google Scholar

• 25

  BreitkreutzD.KoxholtI.ThiemannK.NischtR. (2013). Skin basement membrane: The foundation of epidermal integrity - BM functions and diverse roles of bridging molecules nidogen and perlecan. Biomed. Res. Int., 179784. 10.1155/2013/179784

  • CrossRef
  • Google Scholar

• 26

  BrennerC. A.AdlerR. R.RappoleeD. A.PedersenR. A.WerbZ. (1989). Genes for extracellular-matrix-degrading metalloproteinases and their inhibitor, TIMP, are expressed during early mammalian development. Genes and Development3, 848–859. 10.1101/gad.3.6.848

  • CrossRef
  • Google Scholar

• 27

  BrinckmannJ. (2005). Collagens at a glance. Top. Curr. Chem. (Cham).2005, 1–6. 10.1007/b103817

  • CrossRef
  • Google Scholar

• 28

  BrucknerA. L.LosowM.WiskJ.PatelN.RehaA.LagastH.et al (2020). The challenges of living with and managing epidermolysis bullosa: Insights from patients and caregivers. Orphanet J. Rare Dis.15, 1. 10.1186/s13023-019-1279-y

  • CrossRef
  • Google Scholar

• 29

  Bruckner-TudermanL.McgrathJ. A.RobinsonE. C.UittoJ. (2013). Progress in epidermolysis Bullosa research: Summary of DEBRA international research conference 2012. J. Invest. Dermatol.133, 2121–2126. 10.1038/jid.2013.127

  • CrossRef
  • Google Scholar

• 30

  Bruckner-TudermanL. (2019). Newer treatment modalities in epidermolysis bullosa. Indian dermatol. Online J.10, 244–250. 10.4103/idoj.idoj_287_18

  • CrossRef
  • Google Scholar

• 31

  Bruckner-TudermanL.SchynderU. W.WinterhalterK. H.BrucknerP. (1987). Tissue form of type VII collagen from human skin and dermal fibroblasts in culture. Eur. J. Biochem.165 (3), 607–611. 10.1111/j.1432-1033.1987.tb11483.x

  • CrossRef
  • Google Scholar

• 32

  CaiazzoM.OkawaY.RangaA.PiersigilliA.TabataY.LutolfM. P. (2016). Defined three-dimensional microenvironments boost induction of pluripotency. Nat. Mat.15, 344–352. 10.1038/nmat4536

  • CrossRef
  • Google Scholar

• 33

  CalalbM. B.PolteT. R.HanksS. K. (1995). Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: A role for src family kinases. Mol. Cell. Biol.15, 954–963. 10.1128/mcb.15.2.954

  • CrossRef
  • Google Scholar

• 34

  CalvoF.EgeN.Grande-GarciaA.HooperS.JenkinsR. P.ChaudhryS. I.et al (2013). Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts. Nat. Cell. Biol.15, 637–646. 10.1038/ncb2756

  • CrossRef
  • Google Scholar

• 35

  Campos de CarvalhoA. C.Kasai-BrunswickT. H.Bastos CarvalhoA. (2021). Cell-Based therapies for heart failure. Front. Pharmacol.12, 641116. 10.3389/fphar.2021.641116

  • CrossRef
  • Google Scholar

• 36

  CatelainC.RiveronS.PapadopoulosA.MougenotN.JacquetA.VauchezK.et al (2013). Myoblasts and embryonic stem cells differentially engraft in a mouse model of genetic dilated cardiomyopathy. Mol. Ther.21, 1064–1075. 10.1038/mt.2013.15

  • CrossRef
  • Google Scholar

• 37

  Chacón-MartínezC. A.KoesterJ.WickströmS. A. (2018). Signaling in the stem cell niche: Regulating cell fate, function and plasticity. Development145, dev165399. 10.1242/dev.165399

  • CrossRef
  • Google Scholar

• 38

  ChelakkotC.GhimJ.RyuS. H. (2018). Mechanisms regulating intestinal barrier integrity and its pathological implications. Exp. Mol. Med.50, 1–9. 10.1038/s12276-018-0126-x

  • CrossRef
  • Google Scholar

• 39

  ChenC. S.IngberD. E. (1999). Tensegrity and mechanoregulation: From skeleton to cytoskeleton. Osteoarthr. Cartil.7, 81–94. 10.1053/joca.1998.0164

  • CrossRef
  • Google Scholar

• 40

  ChenD.WangC.-Y. (2019). Targeting cancer stem cells in squamous cell carcinoma. Precis. Clin. Med.2, 152–165. 10.1093/pcmedi/pbz016

  • CrossRef
  • Google Scholar

• 41

  ChenS.LewallenM.XieT. (2013). Adhesion in the stem cell niche: Biological roles and regulation. Dev. Camb.140, 255–265. 10.1242/dev.083139

  • CrossRef
  • Google Scholar

• 42

  ChenX. D.DusevichV.FengJ. Q.ManolagasS. C.JilkaR. L. (2007). Extracellular matrix made by bone marrow cells facilitates expansion of marrow-derived mesenchymal progenitor cells and prevents their differentiation into osteoblasts. J. Bone Min. Res.22, 1943–1956. 10.1359/jbmr.070725

  • CrossRef
  • Google Scholar

• 43

  ChenZ. L.IndykJ. A.StricklandS. (2003). The hippocampal laminin matrix is dynamic and critical for neuronal survival. Mol. Biol. Cell.14, 2665–2676. 10.1091/mbc.E02-12-0832

  • CrossRef
  • Google Scholar

• 44

  ChinthalapudiK.RangarajanE. S.IzardT. (2018). The interaction of talin with the cell membrane is essential for integrin activation and focal adhesion formation. Proc. Natl. Acad. Sci. U. S. A.115, 10339–10344. 10.1073/pnas.1806275115

  • CrossRef
  • Google Scholar

• 45

  ChoiH. R.NamK. M.ParkS. J.KimD. S.HuhC. H.ParkW. Y.et al (2014). Suppression of miR135b increases the proliferative potential of normal human keratinocytes. J. Invest. Dermatol.134, 1161–1164. 10.1038/jid.2013.427

  • CrossRef
  • Google Scholar

• 46

  ChoiS. H.EstarásC.MorescoJ. J.YatesJ. R.JonesK. A. (2013). α-Catenin interacts with APC to regulate β-catenin proteolysis and transcriptional repression of Wnt target genes. Genes. Dev.27, 2473–2488. 10.1101/gad.229062.113

  • CrossRef
  • Google Scholar

• 47

  ChowdhuryF.NaS.LiD.PohY. C.TanakaT. S.WangF.et al (2010). Material properties of the cell dictate stress-induced spreading and differentiation in embryonic stemcells. Nat. Mat.9, 82–88. 10.1038/nmat2563

  • CrossRef
  • Google Scholar

• 48

  ChungC. Y.EricksonH. P. (1997). Glycosaminoglycans modulate fibronectin matrix assembly and are essential for matrix incorporation of tenascin-C. J. Cell. Sci.110 ( Pt 12), 1413–1419. 10.1242/jcs.110.12.1413

  • CrossRef
  • Google Scholar

• 49

  ConnorP.KhairK.LiesnerR.AmroliaP.VeysP.AncliffP.et al (2008). Stem cell transplantation for children with Glanzmann thrombasthenia. Br. J. Haematol.140, 568–571. 10.1111/j.1365-2141.2007.06890.x

  • CrossRef
  • Google Scholar

• 50

  CorcioneA.BenvenutoF.FerrettiE.GiuntiD.CappielloV.CazzantiF.et al (2006). Human mesenchymal stem cells modulate B-cell functions. Blood107, 367–372. 10.1182/blood-2005-07-2657

  • CrossRef
  • Google Scholar

• 51

  CramE. J.ClarkS. G.SchwarzbauerJ. E. (2003). Talin loss-of-function uncovers roles in cell contractility and migration in C. elegans. J. Cell. Sci.116, 3871–3878. 10.1242/jcs.00705

  • CrossRef
  • Google Scholar

• 52

  CroneC.JamesB. (2019). Haemopoietic stem cell transplantation is a curative treatment option with minimal transplant-related complications for patients with severe Glanzmann’s thrombasthenia. Clin. Med. N.19, s34. 10.7861/clinmedicine.19-2-s34

  • CrossRef
  • Google Scholar

• 53

  DaltroS. R. T.MeiraC. S.SantosI. P.Ribeiro dos SantosR.SoaresM. B. P. (2020). Mesenchymal stem cells and atopic dermatitis: A review. Front. Cell. Dev. Biol.8, 326. 10.3389/fcell.2020.00326

  • CrossRef
  • Google Scholar

• 54

  DasP.GoswamiP.DasT. K.NagT.SreenivasV.AhujaV.et al (2012). Comparative tight junction protein expressions in colonic crohn’s disease, ulcerative colitis, and tuberculosis: A new perspective. Virchows Arch.460, 261–270. 10.1007/s00428-012-1195-1

  • CrossRef
  • Google Scholar

• 55

  De RosaL.CarulliS.CocchiarellaF.QuaglinoD.EnzoE.FranchiniE.et al (2014). Long-term stability and safety of transgenic cultured epidermal stem cells in gene therapy of junctional epidermolysis bullosa. Stem Cell. Rep.2, 1–8. 10.1016/j.stemcr.2013.11.001

  • CrossRef
  • Google Scholar

• 56

  DesgrosellierJ. S.SeguinL.BarnesL. A.ShieldsD. J.HuangM.LauS. K.et al (2010). Abstract 3841: An integrin αvβ3/c-Src oncogenic unit promotes anchorage independence and tumor progression. Cancer Res.70, 3841. 10.1158/1538-7445.am10-3841

  • CrossRef
  • Google Scholar

• 57

  Diaz-NavarroR.UrrútiaG.ClelandJ. G. F.PoloniD.VillagranF.Acosta-DigheroR.et al (2021). Stem cell therapy for dilated cardiomyopathy. Cochrane Database Syst. Rev.7, CD013433. 10.1002/14651858.CD013433.pub2

  • CrossRef
  • Google Scholar

• 58

  DietrichC.ScherwatJ.FaustD.OeschF. (2002). Subcellular localization of β-catenin is regulated by cell density. Biochem. Biophys. Res. Commun.292 (1), 195–199. 10.1006/BBRC.2002.6625

  • CrossRef
  • Google Scholar

• 59

  DischerD. E.JanmeyP.WangY. L. (2005). Tissue cells feel and respond to the stiffness of their substrate. Science310, 1139–1143. 10.1126/science.1116995

  • CrossRef
  • Google Scholar

• 60

  DomogatskayaA.RodinS.TryggvasonK. (2012). Functional diversity of laminins. Annu. Rev. Cell. Dev. Biol.28, 523–553. 10.1146/annurev-cellbio-101011-155750

  • CrossRef
  • Google Scholar

• 61

  dos SantosP. B.ZanettiJ. S.Ribeiro-SilvaA.BeltrãoE. I. C. (2012). Beta 1 integrin predicts survival in breast cancer: A clinicopathological and immunohistochemical study. Diagn. Pathol.7, 104. 10.1186/1746-1596-7-104

  • CrossRef
  • Google Scholar

• 62

  DuJ.ZuY.LiJ.DuS.XuY.ZhangL.et al (2016). Extracellular matrix stiffness dictates Wnt expression through integrin pathway. Sci. Rep.6, 20395. 10.1038/srep20395

  • CrossRef
  • Google Scholar

• 63

  DupontS.MorsutL.AragonaM.EnzoE.GiulittiS.CordenonsiM.et al (2011). Role of YAP/TAZ in mechanotransduction. Nature474, 179–183. 10.1038/nature10137

  • CrossRef
  • Google Scholar

• 64

  Duque LasioM. L.KozelB. A. (2018). Elastin-driven genetic diseases. Matrix Biol.71-72, 144–160. 10.1016/j.matbio.2018.02.021

  • CrossRef
  • Google Scholar

• 65

  EnglerA. J.GriffinM. A.SenS.BönnemannC. G.SweeneyH. L.DischerD. E. (2004). Myotubes differentiate optimally on substrates with tissue-like stiffness: Pathological implications for soft or stiff microenvironments. J. Cell. Biol.166, 877–887. 10.1083/jcb.200405004

  • CrossRef
  • Google Scholar

• 66

  EnglerA. J.SenS.SweeneyH. L.DischerD. E. (2006). Matrix elasticity directs stem cell lineage specification. Cell.126, 677–689. 10.1016/j.cell.2006.06.044

  • CrossRef
  • Google Scholar

• 67

  EshkindL.TianQ.SchmidtA.FrankeW. W.WindofferR.LeubeR. E. (2002). Loss of desmoglein 2 suggests essential functions for early embryonic development and proliferation of embryonal stem cells. Eur. J. Cell. Biol.81, 592–598. 10.1078/0171-9335-00278

  • CrossRef
  • Google Scholar

• 68

  EvansM. J.KaufmanM. H. (1981). Establishment in culture of pluripotential cells from mouse embryos. Nature292, 154–156. 10.1038/292154a0

  • CrossRef
  • Google Scholar

• 69

  Even-RamS.ArtymV.YamadaK. M. (2006). Matrix control of stem cell fate. Cell.126, 645–647. 10.1016/j.cell.2006.08.008

  • CrossRef
  • Google Scholar

• 70

  FanY.MeyerT. (2021). Molecular control of cell density-mediated exit to quiescence. Cell. Rep.36, 109436. 10.1016/j.celrep.2021.109436

  • CrossRef
  • Google Scholar

• 71

  FargeE. (2003). Mechanical induction of Twist in the Drosophila foregut/stomodeal primordium. Curr. Biol.13, 1365–1377. 10.1016/S0960-9822(03)00576-1

  • CrossRef
  • Google Scholar

• 72

  FarrukhA.OrtegaF.FanW.MarichalN.PaezJ. I.BerningerB.et al (2017). Bifunctional hydrogels containing the laminin motif IKVAV promote neurogenesis. Stem Cell. Rep.9, 1432–1440. 10.1016/j.stemcr.2017.09.002

  • CrossRef
  • Google Scholar

• 73

  FavreauC.HiguetD.CourvalinJ.-C.BuendiaB. (2004). Expression of a mutant lamin A that causes emery-dreifuss muscular dystrophy inhibits in vitro differentiation of C2C12 myoblasts. Mol. Cell. Biol.24, 1481–1492. 10.1128/mcb.24.4.1481-1492.2004

  • CrossRef
  • Google Scholar

• 74

  FineJ. D.EadyR. A. J.BauerE. A.BauerJ. W.Bruckner-TudermanL.HeagertyA.et al (2008). The classification of inherited epidermolysis bullosa (EB): Report of the third international consensus meeting on diagnosis and classification of EB. J. Am. Acad. Dermatol.58, 931–950. 10.1016/j.jaad.2008.02.004

  • CrossRef
  • Google Scholar

• 75

  ForbesG. M.SturmM. J.LeongR. W.SparrowM. P.SegarajasingamD.CumminsA. G.et al (2014). A phase 2 study of allogeneic mesenchymal stromal cells for luminal crohn’s disease refractory to biologic therapy. Clin. Gastroenterol. Hepatol.12, 64–71. 10.1016/j.cgh.2013.06.021

  • CrossRef
  • Google Scholar

• 76

  FrockR. L.KudlowB. A.EvansA. M.JamesonS. A.HauschkaS. D.KennedyB. K. (2006). Lamin A/C and emerin are critical for skeletal muscle satellite cell differentiation. Genes. Dev.20, 486–500. 10.1101/gad.1364906

  • CrossRef
  • Google Scholar

• 77

  FrühS. M.SchoenI.RiesJ.VogelV. (2015). Molecular architecture of native fibronectin fibrils. Nat. Commun.6, 7275. 10.1038/ncomms8275

  • CrossRef
  • Google Scholar

• 78

  GalanteL. L.SchwarzbauerJ. E. (2007). Requirements for sulfate transport and the diastrophic dysplasia sulfate transporter in fibronectin matrix assembly. J. Cell. Biol.179, 999–1009. 10.1083/jcb.200707150

  • CrossRef
  • Google Scholar

• 79

  GandavarapuN. R.AlgeD. L.AnsethK. S. (2014). Osteogenic differentiation of human mesenchymal stem cells on α5 integrin binding peptide hydrogels is dependent on substrate elasticity. Biomater. Sci.2, 352–361. 10.1039/c3bm60149h

  • CrossRef
  • Google Scholar

• 80

  GangarajuV. K.LinH. (2009). MicroRNAs: Key regulators of stem cells. Nat. Rev. Mol. Cell. Biol.10, 116–125. 10.1038/nrm2621

  • CrossRef
  • Google Scholar

• 81

  GattazzoF.UrciuoloA.BonaldoP. (2014). Extracellular matrix: A dynamic microenvironment for stem cell niche. Biochim. Biophys. Acta1840, 2506–2519. 10.1016/j.bbagen.2014.01.010

  • CrossRef
  • Google Scholar

• 82

  GeeE. P. S.IngberD. E.StultzC. M. (2008). Fibronectin unfolding revisited: Modeling cell traction-mediated unfolding of the tenth type-III repeat. PLoS ONE3, e2373. 10.1371/journal.pone.0002373

  • CrossRef
  • Google Scholar

• 83

  GeorgiadouM.LiljaJ.JacquemetG.GuzmánC.RafaevaM.AlibertC.et al (2017). AMPK negatively regulates tensin-dependent integrin activity. J. Cell. Biol.216, 1107–1121. 10.1083/jcb.201609066

  • CrossRef
  • Google Scholar

• 84

  GhajarC. M.BissellM. J. (2008). Extracellular matrix control of mammary gland morphogenesis and tumorigenesis: Insights from imaging. Histochem. Cell. Biol.130, 1105–1118. 10.1007/s00418-008-0537-1

  • CrossRef
  • Google Scholar

• 85

  GilbertP. M.HavenstriteK. L.MagnussonK. E. G.SaccoA.LeonardiN. A.KraftP.et al (2010). Substrate elasticity regulates skeletal muscle stem cell self-renewal in culture. Science329, 1078–1081. 10.1126/science.1191035

  • CrossRef
  • Google Scholar

• 86

  GlenneyJ. R.ZokasL. (1989). Novel tyrosine kinase substrates from Rous sarcoma virus-transformed cells are present in the membrane skeleton. J. Cell. Biol.108, 2401–2408. 10.1083/jcb.108.6.2401

  • CrossRef
  • Google Scholar

• 87

  GoodmanS. R. (2021). Cell adhesion and the extracellular matrix. Goodman’s Med. Cell. Biol.. 10.1016/b978-0-12-817927-7.00007-7

  • CrossRef
  • Google Scholar

• 88

  GorabiA. M.BanachM.ReinerŽ.PirroM.HajighasemiS.JohnstonT. P.et al (2019). The role of mesenchymal stem cells in atherosclerosis: Prospects for therapy via the modulation of inflammatory milieu. J. Clin. Med.8, E1413. 10.3390/jcm8091413

  • CrossRef
  • Google Scholar

• 89

  GotzmannJ.FoisnerR. (2006). A-Type lamin complexes and regenerative potential: A step towards understanding laminopathic diseases?Histochem. Cell. Biol.125, 33–41. 10.1007/s00418-005-0050-8

  • CrossRef
  • Google Scholar

• 90

  GreenK. J.JaiganeshA.BroussardJ. A. (2019). Desmosomes: Essential contributors to an integrated intercellular junction network. F1000Res.8, F1000. 10.12688/f1000research.20942.1

  • CrossRef
  • Google Scholar

• 91

  GroulxJ. F.GagnéD.BenoitY. D.MartelD.BasoraN.BeaulieuJ. F. (2011). Collagen VI is a basement membrane component that regulates epithelial cell-fibronectin interactions. Matrix Biol.30, 195–206. 10.1016/j.matbio.2011.03.002

  • CrossRef
  • Google Scholar

• 92

  GuanJ.LiY.LuF.FengJ. (2022). Adipose-derived stem cells ameliorate atopic dermatitis by suppressing the IL-17 expression of Th17 cells in an ovalbumin-induced mouse model. Stem Cell. Res. Ther.13, 98. 10.1186/s13287-022-02774-7

  • CrossRef
  • Google Scholar

• 93

  GuerraL.OdorisioT.ZambrunoG.CastigliaD. (2017). Stromal microenvironment in type VII collagen-deficient skin: The ground for squamous cell carcinoma development. Matrix Biol.63, 1–10. 10.1016/j.matbio.2017.01.002

  • CrossRef
  • Google Scholar

• 94

  GuoL.CaiT.ChenK.WangR.WangJ.CuiC.et al (2018). Kindlin-2 regulates mesenchymal stem cell differentiation through control of YAP1/TAZ. J. Cell. Biol.217, 1431–1451. 10.1083/jcb.201612177

  • CrossRef
  • Google Scholar

• 95

  GuoY. P.MartinL. J.HannaW.BanerjeeD.MillerN.FishellE.et al (2001). Growth factors and stromal matrix proteins associated with mammographic densities. Cancer Epidemiol. Biomarkers Prev..

  • Google Scholar

• 96

  HaeckelE. (1868). Natürliche schöpfungsgeschichte: Gemeinverständliche wissenschaftliche - ernst haeckel - google books. Available at: https://books.google.co.in/books?hl=en&lr=&id=Kh4fdEy0OWYC&oi=fnd&pg=PA1&ots=hRgBU1dzQy&sig=uujYiG2vSGZkjHgaWh_p1KMuOdI&redir_esc=y#v=onepage&q&f=false.

  • Google Scholar

• 97

  Hai-YingC.TanakaY.HifumiT.ShojiK.KayeshM. E. H.HashemM. A.et al (2020). Pathological and genetic aspects of spontaneous mammary gland tumor in Tupaia belangeri (tree shrew). PLoS ONE15, e0233232. 10.1371/journal.pone.0233232

  • CrossRef
  • Google Scholar

• 98

  HamidoucheZ.FromiguéO.RingeJ.HäuplT.VaudinP.PagèsJ. C.et al (2009). Priming integrin alpha5 promotes human mesenchymal stromal cell osteoblast differentiation and osteogenesis. Proc. Natl. Acad. Sci. U. S. A.106, 18587–18591. 10.1073/pnas.0812334106

  • CrossRef
  • Google Scholar

• 99

  HamillK. J.KligysK.HopkinsonS. B.JonesJ. C. R. (2009). Laminin deposition in the extracellular matrix: A complex picture emerges. J. Cell. Sci.122, 4409–4417. 10.1242/jcs.041095

  • CrossRef
  • Google Scholar

• 100

  HandorfA. M.ZhouY.HalanskiM. A.LiW. J. (2015). Tissue stiffness dictates development, homeostasis, and disease progression. Organogenesis11, 1–15. 10.1080/15476278.2015.1019687

  • CrossRef
  • Google Scholar

• 101

  HarrisonO. J.BraschJ.LassoG.KatsambaP. S.AhlsenG.HonigB.et al (2016). Structural basis of adhesive binding by desmocollins and desmogleins. Proc. Natl. Acad. Sci. U. S. A.113, 7160–7165. 10.1073/pnas.1606272113

  • CrossRef
  • Google Scholar

• 102

  HayashiY.FurueM. K.OkamotoT.OhnumaK.MyoishiY.FukuharaY.et al (2007). Integrins regulate mouse embryonic stem cell self-renewal. Stem Cells25, 3005–3015. 10.1634/stemcells.2007-0103

  • CrossRef
  • Google Scholar

• 103

  HeZ.DingY.MuY.XuX.KongW.ChaiR.et al (2021). Stem cell-based therapies in hearing loss. Front. Cell. Dev. Biol.9, 730042. 10.3389/fcell.2021.730042

  • CrossRef
  • Google Scholar

• 104

  HirschT.RothoeftT.TeigN.BauerJ. W.PellegriniG.De RosaL.et al (2017). Regeneration of the entire human epidermis using transgenic stem cells. Nature551, 327–332. 10.1038/nature24487

  • CrossRef
  • Google Scholar

• 105

  HolleA. W.TangX.VijayraghavanD.VincentL. G.FuhrmannA.ChoiY. S.et al (2013). In situ mechanotransduction via vinculin regulates stem cell differentiation. Stem Cells31, 2467–2477. 10.1002/stem.1490

  • CrossRef
  • Google Scholar

• 106

  HolstJ.WatsonS.LordM. S.EamegdoolS. S.BaxD. V.Nivison-SmithL. B.et al (2010). Substrate elasticity provides mechanical signals for the expansion of hemopoietic stem and progenitor cells. Nat. Biotechnol.28, 1123–1128. 10.1038/nbt.1687

  • CrossRef
  • Google Scholar

• 107

  HumphreyJ. D.DufresneE. R.SchwartzM. A. (2014). Mechanotransduction and extracellular matrix homeostasis. Nat. Rev. Mol. Cell. Biol.15, 802–812. 10.1038/nrm3896

  • CrossRef
  • Google Scholar

• 108

  HynesR. O. (1986). Fibronectins. Sci. Am.254, 42–51. 10.1038/scientificamerican0686-42

  • CrossRef
  • Google Scholar

• 109

  HynesR. O. (2002). Integrins: Bidirectional, allosteric signaling machines. Cell.110, 673–687. 10.1016/S0092-8674(02)00971-6

  • CrossRef
  • Google Scholar

• 110

  HynesR. O. (1992). Integrins: Versatility, modulation, and signaling in cell adhesion. Cell.69, 11–25. 10.1016/0092-8674(92)90115-S

  • CrossRef
  • Google Scholar

• 111

  HynesR. O. (2009). The extracellular matrix: Not just pretty fibrils. Science326, 1216–1219. 10.1126/science.1176009

  • CrossRef
  • Google Scholar

• 112

  IngberD. E. (2006). Cellular mechanotransduction: Putting all the pieces together again. FASEB J.20, 811–827. 10.1096/fj.05-5424rev

  • CrossRef
  • Google Scholar

• 113

  IngberD. E. (2003). Tensegrity I. Cell structure and hierarchical systems biology. J. Cell. Sci.116, 1157–1173. 10.1242/jcs.00359

  • CrossRef
  • Google Scholar

• 114

  IorioV.TroughtonL. D.HamillK. J. (2015). Laminins: Roles and utility in wound repair. Adv. Wound Care4, 250–263. 10.1089/wound.2014.0533

  • CrossRef
  • Google Scholar

• 115

  IshimotoI.SoharaE.ItoE.OkadoT.RaiT.UchidaS. (2013). Fibronectin glomerulopathy. Clin. Kidney J.6, 513–515. 10.1093/ckj/sft097

  • CrossRef
  • Google Scholar

• 116

  IyerK. V.Piscitello-GómezR.PaijmansJ.JülicherF.EatonS. (2019). Epithelial viscoelasticity is regulated by mechanosensitive E-cadherin turnover. Curr. Biol.29, 578–591.e5. 10.1016/j.cub.2019.01.021

  • CrossRef
  • Google Scholar

• 117

  JaaloukD. E.LammerdingJ. (2009). Mechanotransduction gone awry. Nat. Rev. Mol. Cell. Biol.10, 63–73. 10.1038/nrm2597

  • CrossRef
  • Google Scholar

• 118

  Jabłońska-TrypućA.MatejczykM.RosochackiS. (2016). Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs. J. Enzyme Inhib. Med. Chem.31, 177–183. 10.3109/14756366.2016.1161620

  • CrossRef
  • Google Scholar

• 119

  JansenJ. H. W.EijkenM.JahrH.ChibaH.VerhaarJ. A. N.Van LeeuwenJ. P. T. M.et al (2010). Stretch-induced inhibition of Wnt/beta-catenin signaling in mineralizing osteoblasts. J. Orthop. Res.28, 390–396. 10.1002/jor.20991

  • CrossRef
  • Google Scholar

• 120

  JansenK. A.AthertonP.BallestremC. (2017). Mechanotransduction at the cell-matrix interface. Semin. Cell. Dev. Biol.71, 75–83. 10.1016/j.semcdb.2017.07.027

  • CrossRef
  • Google Scholar

• 121

  JansenK. A.DonatoD. M.BalciogluH. E.SchmidtT.DanenE. H. J.KoenderinkG. H. (2015). A guide to mechanobiology: Where biology and physics meet. Biochim. Biophys. Acta1853, 3043–3052. 10.1016/j.bbamcr.2015.05.007

  • CrossRef
  • Google Scholar

• 122

  JiangY.ZhangP.ZhangX.LvL.ZhouY. (2021). Advances in mesenchymal stem cell transplantation for the treatment of osteoporosis. Cell. Prolif.54, e12956. 10.1111/cpr.12956

  • CrossRef
  • Google Scholar

• 123

  JiaoR.LiuY.YangW. J.ZhuX. Y.LiJ.TangQ. Z. (2014). Effects of stem cell therapy on dilated cardiomyopathy. Saudi Med. J.35, 1463–1468.

  • Google Scholar

• 124

  KanchanawongP.ShtengelG.PasaperaA. M.RamkoE. B.DavidsonM. W.HessH. F.et al (2010). Nanoscale architecture of integrin-based cell adhesions. Nature468, 580–584. 10.1038/nature09621

  • CrossRef
  • Google Scholar

• 125

  KangariP.Talaei-KhozaniT.Razeghian-JahromiI.RazmkhahM. (2020). Mesenchymal stem cells: Amazing remedies for bone and cartilage defects. Stem Cell. Res. Ther.11, 492. 10.1186/s13287-020-02001-1

  • CrossRef
  • Google Scholar

• 126

  KarpowiczP.Willaime-MorawekS.BalenciL.DevealeB.InoueT.Van Der KooyD. (2009). E-Cadherin regulates neural stem cell self-renewal. J. Neurosci.29, 3885–3896. 10.1523/JNEUROSCI.0037-09.2009

  • CrossRef
  • Google Scholar

• 127

  KasperG.GlaeserJ. D.GeisslerS.OdeA.TuischerJ.MatziolisG.et al (2007). Matrix metalloprotease activity is an essential link between mechanical stimulus and mesenchymal stem cell behavior. Stem Cells25, 1985–1994. 10.1634/stemcells.2006-0676

  • CrossRef
  • Google Scholar

• 128

  KaurJ.ReinhardtD. P. (2015). Extracellular matrix (ECM) molecules. Stem Cell. Biol. Tissue Eng. Dent. Sci., 25–45. 10.1016/B978-0-12-397157-9.00003-5

  • CrossRef
  • Google Scholar

• 129

  KaushikG.SpenlehauerA.SessionsA. O.TrujilloA. S.FuhrmannA.FuZ.et al (2015). Vinculin network-mediated cytoskeletal remodeling regulates contractile function in the aging heart. Sci. Transl. Med.7, 292ra99. 10.1126/scitranslmed.aaa5843

  • CrossRef
  • Google Scholar

• 130

  KhadilkarR. J.VoglW.GoodwinK.TanentzapfG. (2017). Modulation of occluding junctions alters the hematopoietic niche to trigger immune activation. ELife6, e28081. 10.7554/eLife.28081

  • CrossRef
  • Google Scholar

• 131

  KhanS.SuryavanshiM.KaurJ.NayakD.KhuranaA.ManchandaR. K.et al (2021). Stem cell therapy: A paradigm shift in breast cancer treatment. World J. Stem Cells13, 841–860. 10.4252/wjsc.v13.i7.841

  • CrossRef
  • Google Scholar

• 132

  KimE.LisbyA.MaC.LoN.EhmerU.HayerK. E.et al (2019). Promotion of growth factor signaling as a critical function of β-catenin during HCC progression. Nat. Commun.10, 1909. 10.1038/s41467-019-09780-z

  • CrossRef
  • Google Scholar

• 133

  KitamuraY.KanayaN.MoleirinhoS.DuW.ReinshagenC.AttiaN.et al (2021). Anti-EGFR VHH-armed death receptor ligand–engineered allogeneic stem cells have therapeutic efficacy in diverse brain metastatic breast cancers. Sci. Adv.7, eabe8671. 10.1126/sciadv.abe8671

  • CrossRef
  • Google Scholar

• 134

  KlassC. M.CouchmanJ. R.WoodsA. (2000). Control of extracellular matrix assembly by syndecan-2 proteoglycan. J. Cell. Sci.113 (3), 493–506. 10.1242/jcs.113.3.493

  • CrossRef
  • Google Scholar

• 135

  KochM.SchulzeJ.HansenU.AshwodtT.KeeneD. R.BrunkenW. J.et al (2004). A novel marker of tissue junctions, collagen XXII. J. Biol. Chem.279, 22514–22521. 10.1074/jbc.M400536200

  • CrossRef
  • Google Scholar

• 136

  KoiralaR.PriestA. V.YenC. F.CheahJ. S.PannekoekW. J.GloerichM.et al (2021). Inside-out regulation of E-cadherin conformation and adhesion. Proc. Natl. Acad. Sci. U. S. A.118, e2104090118. 10.1073/pnas.2104090118

  • CrossRef
  • Google Scholar

• 137

  KourtidisA.NgokS. P.AnastasiadisP. Z. (2013). P120 catenin: An essential regulator of cadherin stability, adhesion-induced signaling, and cancer progression. Prog. Mol. Biol. Transl. Sci.116, 409–432. 10.1016/B978-0-12-394311-8.00018-2

  • CrossRef
  • Google Scholar

• 138

  KucharzikT.WalshS. V.ChenJ.ParkosC. A.NusratA. (2001). Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins. Am. J. Pathol.159–2009. 10.1016/S0002-9440(10)63051-9

  • CrossRef
  • Google Scholar

• 139

  LandyJ.RondeE.EnglishN.ClarkS. K.HartA. L.KnightS. C.et al (2016). Tight junctions in inflammatory bowel diseases and inflammatory bowel disease associated colorectal cancer. World J. Gastroenterol.22, 3117–3126. 10.3748/wjg.v22.i11.3117

  • CrossRef
  • Google Scholar

• 140

  LarueL.OhsugiM.HirchenhainJ.KemlerR. (1994). E-cadherin null mutant embryos fail to form a trophectoderm epithelium. Proc. Natl. Acad. Sci. U. S. A.91, 8263–8267. 10.1073/pnas.91.17.8263

  • CrossRef
  • Google Scholar

• 141

  LathiaJ. D.PattonB.EckleyD. M.MagnusT.MughalM. R.SasakiT.et al (2007). Patterns of laminins and integrins in the embryonic ventricular zone of the CNS. J. Comp. Neurol.505, 630–643. 10.1002/cne.21520

  • CrossRef
  • Google Scholar

• 142

  LeBleuV.SugimotoH.MundelT. M.Gerami-NainiB.FinanE.MillerC. A.et al (2009). Stem cell therapies benefit Alport syndrome. J. Am. Soc. Nephrol.20, 2359–2370. 10.1681/ASN.2009010123

  • CrossRef
  • Google Scholar

• 143

  LeblondC. P. (1964). Classification of cell populations on the basis of their proliferative behavior. Natl. Cancer Inst. Monogr.14, 119–150.

  • Google Scholar

• 144

  LeeB.MoonK. M.KimC. Y. (2018). Tight junction in the intestinal epithelium: Its association with diseases and regulation by phytochemicals. J. Immunol. Res.2018, 2645465. 10.1155/2018/2645465

  • CrossRef
  • Google Scholar

• 145

  LeeM.JiH.FurutaY.ParkJ. I.McCreaP. D. (2014). p120-catenin regulates REST and CoREST, and modulates mouse embryonic stem cell differentiation. J. Cell. Sci.127, 4037–4051. 10.1242/jcs.151944

  • CrossRef
  • Google Scholar

• 146

  LiB.DaggettV. (2002). Molecular basis for the extensibility of elastin. J. Muscle Res. Cell. Motil.23, 561–573. 10.1023/A:1023474909980

  • CrossRef
  • Google Scholar

• 147

  LiB.MoshfeghC.LinZ.AlbuschiesJ.VogelV. (2013). Mesenchymal stem cells exploit extracellular matrix as mechanotransducer. Sci. Rep.3, 2425. 10.1038/srep02425

  • CrossRef
  • Google Scholar

• 148

  LiD.ZhouJ.ChowdhuryF.ChengJ.WangN.WangF. (2011). Role of mechanical factors in fate decisions of stem cells. Regen. Med.6, 229–240. 10.2217/rme.11.2

  • CrossRef
  • Google Scholar

• 149

  LiN.LongB.HanW.YuanS.WangK. (2017). MicroRNAs: Important regulators of stem cells. Stem Cell. Res. Ther.8, 110. 10.1186/s13287-017-0551-0

  • CrossRef
  • Google Scholar

• 150

  LinY.ZhuW.ChenX. (2020). The involving progress of MSCs based therapy in atherosclerosis. Stem Cell. Res. Ther.11, 216. 10.1186/s13287-020-01728-1

  • CrossRef
  • Google Scholar

• 151

  LinsleyC.WuB.TawilB. (2013). The effect of fibrinogen, collagen type I, and fibronectin on mesenchymal stem cell growth and differentiation into osteoblasts. Tissue Eng. Part A19, 1416–1423. 10.1089/ten.tea.2012.0523

  • CrossRef
  • Google Scholar

• 152

  LiuC.HanD.LiangP.LiY.CaoF. (2021). The current dilemma and breakthrough of stem cell therapy in ischemic heart disease. Front. Cell. Dev. Biol.9, 636136. 10.3389/fcell.2021.636136

  • CrossRef
  • Google Scholar

• 153

  LiuG.DavidB. T.TrawczynskiM.FesslerR. G. (2020). Advances in pluripotent stem cells: History, mechanisms, technologies, and applications. Stem Cell. Rev. Rep.16, 3–32. 10.1007/s12015-019-09935-x

  • CrossRef
  • Google Scholar

• 154

  LoC. M.WangH. B.DemboM.WangY. L. (2000). Cell movement is guided by the rigidity of the substrate. Biophys. J.79, 144–152. 10.1016/S0006-3495(00)76279-5

  • CrossRef
  • Google Scholar

• 155

  López-GarcíaA.RoviraM.Jauregui-AmezagaA.MarínP.BarasteguiR.SalasA.et al (2017). Autologous haematopoietic stem cell transplantation for refractory crohn’s disease: Efficacy in a single-centre cohort. J. Crohns Colitis11, 1161–1168. 10.1093/ecco-jcc/jjx054

  • CrossRef
  • Google Scholar

• 156

  LundD. K.MoulyV.CornelisonD. D. W. (2014). MMP-14 is necessary but not sufficient for invasion of three-dimensional collagen by human muscle satellite cells. Am. J. Physiol. Cell. Physiol.307, C140–C149. 10.1152/ajpcell.00032.2014

  • CrossRef
  • Google Scholar

• 157

  MahlaR. S. (2016). Stem cells applications in regenerative medicine and disease therapeutics. Int. J. Cell. Biol.2016, 6940283. 10.1155/2016/6940283

  • CrossRef
  • Google Scholar

• 158

  MarinkovichM. P.TangJ. Y. (2019). Gene therapy for epidermolysis bullosa. J. Invest. Dermatol.139, 1221–1226. 10.1016/j.jid.2018.11.036

  • CrossRef
  • Google Scholar

• 159

  MartinoM. M.MochizukiM.RothenfluhD. A.RempelS. A.HubbellJ. A.BarkerT. H. (2009). Controlling integrin specificity and stem cell differentiation in 2D and 3D environments through regulation of fibronectin domain stability. Biomaterials30, 1089–1097. 10.1016/j.biomaterials.2008.10.047

  • CrossRef
  • Google Scholar

• 160

  MasonC.DunnillP. (2008). A brief definition of regenerative medicine. Regen. Med.3, 1–5. 10.2217/17460751.3.1.1

  • CrossRef
  • Google Scholar

• 161

  MathieuP. S.LoboaE. G. (2012). Cytoskeletal and focal adhesion influences on mesenchymal stem cell shape, mechanical properties, and differentiation down osteogenic, adipogenic, and chondrogenic pathways. Tissue Eng. Part B Rev.18, 436–444. 10.1089/ten.teb.2012.0014

  • CrossRef
  • Google Scholar

• 162

  MatrisianL. M.HoganB. L. M. (1990). Growth factor-regulated proteases and extracellular matrix remodeling during mammalian development. Curr. Top. Dev. Biol.24, 219–259. 10.1016/S0070-2153(08)60089-7

  • CrossRef
  • Google Scholar

• 163

  MavilioF.PellegriniG.FerrariS.Di NunzioF.Di IorioE.RecchiaA.et al (2006). Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells. Nat. Med.12, 1397–1402. 10.1038/nm1504

  • CrossRef
  • Google Scholar

• 164

  MechamR. P. (1991). Elastin synthesis and fiber assembly. Ann. N. Y. Acad. Sci.624, 137–146. 10.1111/j.1749-6632.1991.tb17013.x

  • CrossRef
  • Google Scholar

• 165

  MisselwitzB.JuilleratP.SulzM. C.SiegmundB.BrandS.Swiss IBDnet, an official working group of the Swiss Society of Gastroenterology (2020). Emerging treatment options in inflammatory bowel disease: Janus kinases, stem cells, and more. Digestion101, 69–82. 10.1159/000507782

  • CrossRef
  • Google Scholar

• 166

  MohammedD.VersaevelM.BruyèreC.AlaimoL.LucianoM.VercruysseE.et al (2019). Innovative tools for mechanobiology: Unraveling outside-in and inside-out mechanotransduction. Front. Bioeng. Biotechnol.7, 162. 10.3389/fbioe.2019.00162

  • CrossRef
  • Google Scholar

• 167

  MonkleyS. J.ZhouX. H.KinstonS. J.GiblettS. M.HemmingsL.PriddleH.et al (2000). Disruption of the talin gene arrests mouse development at the gastrulation stage. Dev. Dyn.219, 560–574. 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1079>3.0.CO;2-Y

  • CrossRef
  • Google Scholar

• 168

  MorgnerJ.GhatakS.JakobiT.DieterichC.AumailleyM.WickströmS. A. (2015). Integrin-linked kinase regulates the niche of quiescent epidermal stem cells. Nat. Commun.6, 8198. 10.1038/ncomms9198

  • CrossRef
  • Google Scholar

• 169

  MorlaA.RuoslahtiE. (1992). A fibronectin self-assembly site involved in fibronectin matrix assembly: Reconstruction in a synthetic peptide. J. Cell. Biol.118, 421–429. 10.1083/jcb.118.2.421

  • CrossRef
  • Google Scholar

• 170

  MousavizadehR.HojabrpourP.EltitF.McDonaldP. C.DedharS.McCormackR. G.et al (2020). β1 integrin, ILK and mTOR regulate collagen synthesis in mechanically loaded tendon cells. Sci. Rep.10, 12644. 10.1038/s41598-020-69267-6

  • CrossRef
  • Google Scholar

• 171

  Murphy-UllrichJ. E.SageE. H. (2014). Revisiting the matricellular concept. Matrix Biol.37, 1–14. 10.1016/j.matbio.2014.07.005

  • CrossRef
  • Google Scholar

• 172

  NakanoA.PulkkinenL.MurrellD.RicoJ.LuckyA. W.GarzonM.et al (2001). Epidermolysis bullosa with congenital pyloric atresia: Novel mutations in the β4 integrin gene (ITGB4) and genotype/phenotype correlations. Pediatr. Res.49, 618–626. 10.1203/00006450-200105000-00003

  • CrossRef
  • Google Scholar

• 173

  NaqviS. M.McNamaraL. M. (2020). Stem cell mechanobiology and the role of biomaterials in governing mechanotransduction and matrix production for tissue regeneration. Front. Bioeng. Biotechnol.8, 597661. 10.3389/fbioe.2020.597661

  • CrossRef
  • Google Scholar

• 174

  NascimentoM. A.SorokinL.Coelho-SampaioT. (2018). Fractone bulbs derive from ependymal cells and their laminin composition influence the stem cell niche in the subventricular zone. J. Neurosci.38, 3880–3889. 10.1523/JNEUROSCI.3064-17.2018

  • CrossRef
  • Google Scholar

• 175

  NathS. C.DayB.HarperL.YeeJ.HsuC. Y. M.LarijaniL.et al (2021). Fluid shear stress promotes embryonic stem cell pluripotency via interplay between β-catenin and vinculin in bioreactor culture. Stem Cells39, 1166–1177. 10.1002/stem.3382

  • CrossRef
  • Google Scholar

• 176

  NiessenC. M.GottardiC. J. (2008). Molecular components of the adherens junction. Biochim. Biophys. Acta1778, 562–571. 10.1016/j.bbamem.2007.12.015

  • CrossRef
  • Google Scholar

• 177

  NusseR. (2008). Wnt signaling and stem cell control. Cell. Res.18, 523–527. 10.1038/cr.2008.47

  • CrossRef
  • Google Scholar

• 178

  NyengP.HeilmannS.Löf-ÖhlinZ. M.PetterssonN. F.HermannF. M.ReynoldsA. B.et al (2019). p120ctn-Mediated organ patterning precedes and determines pancreatic progenitor fate. Dev. Cell.49, 31–47.e9. 10.1016/j.devcel.2019.02.005

  • CrossRef
  • Google Scholar

• 179

  OakesP. W.GardelM. L. (2014). Stressing the limits of focal adhesion mechanosensitivity. Curr. Opin. Cell. Biol.30, 68–73. 10.1016/j.ceb.2014.06.003

  • CrossRef
  • Google Scholar

• 180

  OguraN.KawadaM.ChangW. J.ZhangQ.LeeS. Y.KondohT.et al (2004). Differentiation of the human mesenchymal stem cells derived from bone marrow and enhancement of cell attachment by fibronectin. J. Oral Sci.46, 207–213. 10.2334/josnusd.46.207

  • CrossRef
  • Google Scholar

• 181

  OshimaT.MiwaH.JohT. (2008). Changes in the expression of claudins in active ulcerative colitis. J. Gastroenterol. Hepatol.23, S146–S150. 10.1111/j.1440-1746.2008.05405.x

  • CrossRef
  • Google Scholar

• 182

  OzsvarJ.MithieuxS. M.WangR.WeissA. S. (2015). Elastin-based biomaterials and mesenchymal stem cells. Biomater. Sci.3, 800–809. 10.1039/c5bm00038f

  • CrossRef
  • Google Scholar

• 183

  OzsvarJ.YangC.CainS. A.BaldockC.TarakanovaA.WeissA. S. (2021). Tropoelastin and elastin assembly. Front. Bioeng. Biotechnol.9, 643110. 10.3389/fbioe.2021.643110

  • CrossRef
  • Google Scholar

• 184

  PaavolainenO.PeuhuE. (2021). Integrin-mediated adhesion and mechanosensing in the mammary gland. Semin. Cell. Dev. Biol.114, 113–125. 10.1016/j.semcdb.2020.10.010

  • CrossRef
  • Google Scholar

• 185

  PaiS. G.CarneiroB. A.MotaJ. M.CostaR.LeiteC. A.Barroso-SousaR.et al (2017). Wnt/beta-catenin pathway: Modulating anticancer immune response. J. Hematol. Oncol.10, 101. 10.1186/s13045-017-0471-6

  • CrossRef
  • Google Scholar

• 186

  PancieraT.AzzolinL.CordenonsiM.PiccoloS. (2017). Mechanobiology of YAP and TAZ in physiology and disease. Nat. Rev. Mol. Cell. Biol.18, 758–770. 10.1038/nrm.2017.87

  • CrossRef
  • Google Scholar

• 187

  PancieraT.CitronA.Di BiagioD.BattilanaG.GandinA.GiulittiS.et al (2020). Publisher Correction: Reprogramming normal cells into tumour precursors requires ECM stiffness and oncogene-mediated changes of cell mechanical properties. Nat. Mat.19, 475. 10.1038/s41563-020-0615-x10.1038/s41563-020-0644-5

  • CrossRef
  • Google Scholar

• 188

  PanésJ.García-OlmoD.Van AsscheG.ColombelJ. F.ReinischW.BaumgartD. C.et al (2016). Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in crohn’s disease: A phase 3 randomised, double-blind controlled trial. Lancet388, 1281–1290. 10.1016/S0140-6736(16)31203-X

  • CrossRef
  • Google Scholar

• 189

  PankovR.YamadaK. M. (2002). Fibronectin at a glance. J. Cell. Sci.115, 3861–3863. 10.1242/jcs.00059

  • CrossRef
  • Google Scholar

• 190

  PannekoekW. J.de RooijJ.GloerichM. (2019). Force transduction by cadherin adhesions in morphogenesis. In F1000Research8, F1000. 10.12688/f1000research.18779.1

  • CrossRef
  • Google Scholar

• 191

  ParisiL.ToffoliA.GhezziB.MozzoniB.LumettiS.MacalusoG. M. (2020). A glance on the role of fibronectin in controlling cell response at biomaterial interface. Jpn. Dent. Sci. Rev.56, 50–55. 10.1016/j.jdsr.2019.11.002

  • CrossRef
  • Google Scholar

• 192

  ParkC. C.ZhangH.PallaviciniM.GrayJ. W.BaehnerF.ParkC. J.et al (2006). Beta1 integrin inhibitory antibody induces apoptosis of breast cancer cells, inhibits growth, and distinguishes malignant from normal phenotype in three dimensional cultures and in vivo. Cancer Res.66, 1526–1535. 10.1158/0008-5472.CAN-05-3071

  • CrossRef
  • Google Scholar

• 193

  ParkG. C.KimH. S.ParkH. Y.SeoY.KimJ. M.ShinS. C.et al (2019). Tensin-3 regulates integrin-mediated proliferation and differentiation of tonsil-derived mesenchymal stem cells. Cells9, E89. 10.3390/cells9010089

  • CrossRef
  • Google Scholar

• 194

  ParkJ.SonY.LeeN. G.LeeK.LeeD. G.SongJ.et al (2018). DSG2 is a functional cell surface marker for identification and isolation of human pluripotent stem cells. Stem Cell. Rep.11, 115–127. 10.1016/j.stemcr.2018.05.009

  • CrossRef
  • Google Scholar

• 195

  PaszekM. J.ZahirN.JohnsonK. R.LakinsJ. N.RozenbergG. I.GefenA.et al (2005). Tensional homeostasis and the malignant phenotype. Cancer Cell.8, 241–254. 10.1016/j.ccr.2005.08.010

  • CrossRef
  • Google Scholar

• 196

  PattenJ.WangK. (2021). Fibronectin in development and wound healing. Adv. Drug Deliv. Rev.170, 353–368. 10.1016/j.addr.2020.09.005

  • CrossRef
  • Google Scholar

• 197

  PengT.DongY.ZhuG.XieD. (2014). Induced pluripotent stem cells: Landscape for studying and treating hereditary hearing loss. J. Otology9, 151–155. 10.1016/j.joto.2015.02.001

  • CrossRef
  • Google Scholar

• 198

  PetrofG.LwinS. M.Martinez-QueipoM.Abdul-WahabA.TsoS.MellerioJ. E.et al (2015). Potential of systemic allogeneic mesenchymal stromal cell therapy for children with recessive dystrophic epidermolysis bullosa. J. Invest. Dermatol.135, 2319–2321. 10.1038/jid.2015.158

  • CrossRef
  • Google Scholar

• 199

  PietersT.GoossensS.HaenebalckeL.AndriesV.StryjewskaA.De RyckeR.et al (2016). p120 catenin-mediated stabilization of E-cadherin is essential for primitive endoderm specification. PLoS Genet.12, e1006243. 10.1371/journal.pgen.1006243

  • CrossRef
  • Google Scholar

• 200

  PimtonP.SarkarS.ShethN.PeretsA.MarcinkiewiczC.LazaroviciP.et al (2011). Fibronectin-mediated upregulation of α5β1 integrin and cell adhesion during differentiation of mouse embryonic stem cells. Cell. adh. Migr.5, 73–82. 10.4161/cam.5.1.13704

  • CrossRef
  • Google Scholar

• 201

  PolteT. R.HanksS. K. (1997). Complexes of focal adhesion kinase (FAK) and Crk-associated substrate (p130(Cas)) are elevated in cytoskeleton-associated fractions following adhesion and Src transformation. Requirements for Src kinase activity and FAK proline-rich motifs. J. Biol. Chem.272, 5501–5509. 10.1074/jbc.272.9.5501

  • CrossRef
  • Google Scholar

• 202

  PonmuruganM.VemparalaS. (2012). Studies on structural and average unfolding behaviours of FNIII domain of Contactin-1 protein by molecular dynamics simulation. Front. Life Sci.6, 33–45. 10.1080/21553769.2013.776995

  • CrossRef
  • Google Scholar

• 203

  PouikliA.ParekhS.MaleszewskaM.NikopoulouC.BaghdadiM.TripodiI.et al (2021). Chromatin remodeling due to degradation of citrate carrier impairs osteogenesis of aged mesenchymal stem cells. Nat. Aging1, 810–825. 10.1038/s43587-021-00105-8

  • CrossRef
  • Google Scholar

• 204

  PrasadS.MingrinoR.KaukinenK.HayesK. L.PowellR. M.MacDonaldT. T.et al (2005). Inflammatory processes have differential effects on claudins 2, 3 and 4 in colonic epithelial cells. Lab. Invest.85, 1139–1162. 10.1038/labinvest.3700316

  • CrossRef
  • Google Scholar

• 205

  ProctorR. A. (1987). Fibronectin: A brief overview of its structure, function, and physiology. Rev. Infect. Dis.9, S317–S321. 10.1093/clinids/9.supplement_4.s317

  • CrossRef
  • Google Scholar

• 206

  ProdingerC.ReicheltJ.BauerJ. W.LaimerM. (2019). Epidermolysis bullosa: Advances in research and treatment. Exp. Dermatol.28, 1176–1189. 10.1111/exd.13979

  • CrossRef
  • Google Scholar

• 207

  ProvenzanoP. P.KeelyP. J. (2009). The role of focal adhesion kinase in tumor initiation and progression. Cell. adh. Migr.3, 347–350. 10.4161/cam.3.4.9458

  • CrossRef
  • Google Scholar

• 208

  QasimW.Cavazzana-CalvoM.DaviesE. G.DavisJ.DuvalM.EamesG.et al (2009). Allogeneic hematopoietic stem-cell transplantation for leukocyte adhesion deficiency. Pediatrics123, 836–840. 10.1542/peds.2008-1191

  • CrossRef
  • Google Scholar

• 209

  QinL.FuX.MaJ.LinM.ZhangP.WangY.et al (2021). Kindlin-2 mediates mechanotransduction in bone by regulating expression of Sclerostin in osteocytes. Commun. Biol.4, 402. 10.1038/s42003-021-01950-4

  • CrossRef
  • Google Scholar

• 210

  RashidghamatE.McGrathJ. A. (2017). Novel and emerging therapies in the treatment of recessive dystrophic epidermolysis bullosa. Intractable Rare Dis. Res.6, 6–20. 10.5582/irdr.2017.01005

  • CrossRef
  • Google Scholar

• 211

  RaymondK.DeugnierM. A.FaraldoM. M.GlukhovaM. A. (2009). Adhesion within the stem cell niches. Curr. Opin. Cell. Biol.21, 623–629. 10.1016/j.ceb.2009.05.004

  • CrossRef
  • Google Scholar

• 212

  RedmerT.DieckeS.GrigoryanT.Quiroga-NegreiraA.BirchmeierW.BesserD. (2011). E-cadherin is crucial for embryonic stem cell pluripotency and can replace OCT4 during somatic cell reprogramming. EMBO Rep.12, 720–726. 10.1038/embor.2011.88

  • CrossRef
  • Google Scholar

• 213

  RelucioJ.MenezesM. J.Miyagoe-SuzukiY.TakedaS.ColognatoH. (2012). Laminin regulates postnatal oligodendrocyte production by promoting oligodendrocyte progenitor survival in the subventricular zone. GLIA60, 1451–1467. 10.1002/glia.22365

  • CrossRef
  • Google Scholar

• 214

  RenG.ZhangL.ZhaoX.XuG.ZhangY.RobertsA. I.et al (2008). Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell. Stem Cell.2, 141–150. 10.1016/j.stem.2007.11.014

  • CrossRef
  • Google Scholar

• 215

  ReynoldsA. B.DanielJ.McCreaP. D.WheelockM. J.WuJ.ZhangZ. (1994). Identification of a new catenin: The tyrosine kinase substrate p120cas associates with E-cadherin complexes. Mol. Cell. Biol.14, 8333–8342. 10.1128/mcb.14.12.8333-8342.1994

  • CrossRef
  • Google Scholar

• 216

  Ricard-BlumS. (2011). The collagen family. Cold Spring Harb. Perspect. Biol.3, a004978. 10.1101/cshperspect.a004978

  • CrossRef
  • Google Scholar

• 217

  RigilloG.BasileV.BellutiS.RonzioM.SautaE.CiarrocchiA.et al (2021). The transcription factor NF-Y participates to stem cell fate decision and regeneration in adult skeletal muscle. Nat. Commun.12, 6013. 10.1038/s41467-021-26293-w

  • CrossRef
  • Google Scholar

• 218

  RobeyP. G. (2000). Series Introduction: Stem cells near the century mark. J. Clin. Invest.105, 1489–1491. 10.1172/jci10256

  • CrossRef
  • Google Scholar

• 219

  RodgersU. R.WeissA. S. (2004). Integrin αvβ3 binds a unique non-RGD site near the C-terminus of human tropoelastin. Biochimie86, 173–178. 10.1016/j.biochi.2004.03.002

  • CrossRef
  • Google Scholar

• 220

  RosenbloomJ.AbramsW. R.MechamR. (1993). Extracellular matrix 4: The elastic fiber. FASEB J.7, 1208–1218. 10.1096/fasebj.7.13.8405806

  • CrossRef
  • Google Scholar

• 221

  RowlandsA. S.GeorgeP. A.Cooper-WhiteJ. J. (2008). Directing osteogenic and myogenic differentiation of MSCs: Interplay of stiffness and adhesive ligand presentation. Am. J. Physiol. Cell. Physiol.295, C1037–C1044. 10.1152/ajpcell.67.2008

  • CrossRef
  • Google Scholar

• 222

  SalasznykR. M.KleesR. F.BoskeyA.PlopperG. E. (2007). Activation of FAK is necessary for the osteogenic differentiation of human mesenchymal stem cells on laminin-5. J. Cell. Biochem.100, 499–514. 10.1002/jcb.21074

  • CrossRef
  • Google Scholar

• 223

  SamantaD.AlmoS. C. (2015). Nectin family of cell-adhesion molecules: Structural and molecular aspects of function and specificity. Cell. Mol. Life Sci.72, 645–658. 10.1007/s00018-014-1763-4

  • CrossRef
  • Google Scholar

• 224

  SarpalR.YanV.KazakovaL.SheppardL.YuJ. C.Fernandez-GonzalezR.et al (2019). Role of α-Catenin and its mechanosensing properties in regulating Hippo/YAP-dependent tissue growth. PLoS Genet.15, e1008454. 10.1371/journal.pgen.1008454

  • CrossRef
  • Google Scholar

• 225

  SawS.WeissA.KhokhaR.WaterhouseP. D. (2019). Metalloproteases: On the watch in the hematopoietic niche. Trends Immunol.40, 1053–1070. 10.1016/j.it.2019.09.006

  • CrossRef
  • Google Scholar

• 226

  SawadaN. (2013). Tight junction-related human diseases. Pathol. Int.63, 1–12. 10.1111/pin.12021

  • CrossRef
  • Google Scholar

• 227

  SchallerM. D. (2001). Paxillin: A focal adhesion-associated adaptor protein. Oncogene20, 6459–6472. 10.1038/sj.onc.1204786

  • CrossRef
  • Google Scholar

• 228

  SchillerH. B.FässlerR. (2013). Mechanosensitivity and compositional dynamics of cell-matrix adhesions. EMBO Rep.14, 509–519. 10.1038/embor.2013.49

  • CrossRef
  • Google Scholar

• 229

  SchlaepferD. D.HanksS. K.HunterT.GeerP. Van Der. (1994). Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase. Nature372, 786–791. 10.1038/372786a0

  • CrossRef
  • Google Scholar

• 230

  SchlegelmilchK.MohseniM.KirakO.PruszakJ.RodriguezJ. R.ZhouD.et al (2011). Yap1 acts downstream of α-catenin to control epidermal proliferation. Cell.144, 782–795. 10.1016/j.cell.2011.02.031

  • CrossRef
  • Google Scholar

• 231

  SchofieldR. (1978). The relationship between the spleen colony-forming cell and the haemopoietic stem cell. A hypothesis. Blood Cells.

  • Google Scholar

• 232

  SeitaJ.WeissmanI. L. (2010). Hematopoietic stem cell: Self-renewal versus differentiation. Wiley Interdiscip. Rev. Syst. Biol. Med.2, 640–653. 10.1002/wsbm.86

  • CrossRef
  • Google Scholar

• 233

  SeoC. H.FurukawaK.MontagneK.JeongH.UshidaT. (2011). The effect of substrate microtopography on focal adhesion maturation and actin organization via the RhoA/ROCK pathway. Biomaterials32, 9568–9575. 10.1016/j.biomaterials.2011.08.077

  • CrossRef
  • Google Scholar

• 234

  ShahoumiL. A. (2021). Oral cancer stem cells: Therapeutic implications and challenges. Front. Oral Health2, 685236. 10.3389/froh.2021.685236

  • CrossRef
  • Google Scholar

• 235

  ShamblottM. J.AxelmanJ.WangS.BuggE. M.LittlefieldJ. W.DonovanP. J.et al (1998). Derivation of pluripotent stem cells from cultured human primordial germ cells. Proc. Natl. Acad. Sci. U. S. A.95, 13726–13731. 10.1073/pnas.95.23.13726

  • CrossRef
  • Google Scholar

• 236

  ShenQ.WangY.KokovayE.LinG.ChuangS. M.GoderieS. K.et al (2008). Adult SVZ stem cells lie in a vascular niche: A quantitative analysis of niche cell-cell interactions. Cell. Stem Cell.3, 289–300. 10.1016/j.stem.2008.07.026

  • CrossRef
  • Google Scholar

• 237

  ShibataS.HayashiR.OkuboT.KudoY.KatayamaT.IshikawaY.et al (2018). Selective laminin-directed differentiation of human induced pluripotent stem cells into distinct ocular lineages. Cell. Rep.25, 1668–1679.e5. 10.1016/j.celrep.2018.10.032

  • CrossRef
  • Google Scholar

• 238

  ShihY. R. V.TsengK. F.LaiH. Y.LinC. H.LeeO. K. (2011). Matrix stiffness regulation of integrin-mediated mechanotransduction during osteogenic differentiation of human mesenchymal stem cells. J. Bone Min. Res.26, 730–738. 10.1002/jbmr.278

  • CrossRef
  • Google Scholar

• 239

  ShimizuH.SuzukiK.WatanabeM.OkamotoR. (2019). Stem cell-based therapy for inflammatory bowel disease. Intest. Res.17, 311–316. 10.5217/ir.2019.00043

  • CrossRef
  • Google Scholar

• 240

  ShouldersM. D.RainesR. T. (2009). Collagen structure and stability. Annu. Rev. Biochem.78, 929–958. 10.1146/annurev.biochem.77.032207.120833

  • CrossRef
  • Google Scholar

• 241

  SilvisM. R.KregerB. T.LienW. H.KlezovitchO.RudakovaG. M.CamargoF. D.et al (2011). α-catenin is a tumor suppressor that controls cell accumulation by regulating the localization and activity of the transcriptional coactivator yap1. Sci. Signal.4, ra33. 10.1126/scisignal.2001823

  • CrossRef
  • Google Scholar

• 242

  SmithA. G. (2001). Embryo-derived stem cells: Of mice and men. Annu. Rev. Cell. Dev. Biol.17, 435–462. 10.1146/annurev.cellbio.17.1.435

  • CrossRef
  • Google Scholar

• 243

  SmithL.ChoS.DischerD. E. (2017). Mechanosensing of matrix by stem cells: From matrix heterogeneity, contractility, and the nucleus in pore-migration to cardiogenesis and muscle stem cells in vivo. Semin. Cell. Dev. Biol.71, 84–98. 10.1016/j.semcdb.2017.05.025

  • CrossRef
  • Google Scholar

• 244

  SomaiahC.KumarA.MawrieD.SharmaA.PatilS. D.BhattacharyyaJ.et al (2015). Collagen promotes higher adhesion, survival and proliferation of mesenchymal stem cells. PLoS ONE10, e0145068. 10.1371/journal.pone.0145068

  • CrossRef
  • Google Scholar

• 245

  SpiegelmanB. M.GintyC. A. (1983). Fibronectin modulation of cell shape and lipogenic gene expression in 3t3-adipocytes. Cell.35, 657–666. 10.1016/0092-8674(83)90098-3

  • CrossRef
  • Google Scholar

• 246

  StantonA. E.TongX.YangF. (2019). Extracellular matrix type modulates mechanotransduction of stem cells. Acta Biomater.96, 310–320. 10.1016/j.actbio.2019.06.048

  • CrossRef
  • Google Scholar

• 247

  StepenskyP. Y.WolachB.GavrieliR.RoussoS.AmiT. B.GoldmanV.et al (2015). Leukocyte adhesion deficiency type III: Clinical features and treatment with stem cell transplantation. J. Pediatr. Hematol. Oncol.37, 264–268. 10.1097/MPH.0000000000000228

  • CrossRef
  • Google Scholar

• 248

  StepniakE.RadiceG. L.VasioukhinV. (2009). Adhesive and signaling functions of cadherins and catenins in vertebrate development. Cold Spring Harb. Perspect. Biol.1, a002949. 10.1101/cshperspect.a002949

  • CrossRef
  • Google Scholar

• 249

  SumaG.AroraM.LakhanpalM. (2015). Stem cell therapy: A novel treatment approach for oral mucosal lesions. J. Pharm. Bioallied Sci.7, 2–8. 10.4103/0975-7406.149809

  • CrossRef
  • Google Scholar

• 250

  SunZ.GuoS. S.FässlerR. (2016). Integrin-mediated mechanotransduction. J. Cell. Biol.215, 445–456. 10.1083/jcb.201609037

  • CrossRef
  • Google Scholar

• 251

  SzymanskiJ. M.SevcikE. N.ZhangK.FeinbergA. W. (2017). Stretch-dependent changes in molecular conformation in fibronectin nanofibers. Biomater. Sci.5, 1629–1639. 10.1039/c7bm00370f

  • CrossRef
  • Google Scholar

• 252

  SzymanskiJ. M.ZhangK.FeinbergA. W. (2017). Measuring the Poisson’s ratio of fibronectin using engineered nanofibers. Sci. Rep.7, 13413. 10.1038/s41598-017-13866-3

  • CrossRef
  • Google Scholar

• 253

  Takenaka-NinagawaN.KimJ.ZhaoM.SatoM.JonouchiT.GotoM.et al (2021). Collagen-VI supplementation by cell transplantation improves muscle regeneration in Ullrich congenital muscular dystrophy model mice. Stem Cell. Res. Ther.12, 446. 10.1186/s13287-021-02514-3

  • CrossRef
  • Google Scholar

• 254

  Tamayo-AngorrillaM.López de AndrésJ.JiménezG.MarchalJ. A. (2021). The biomimetic extracellular matrix: A therapeutic tool for breast cancer research. Transl. Res.247, 117–136. 10.1016/J.TRSL.2021.11.008

  • CrossRef
  • Google Scholar

• 255

  TheocharisA. D.SkandalisS. S.GialeliC.KaramanosN. K. (2016). Extracellular matrix structure. Adv. Drug Deliv. Rev.97, 4–27. 10.1016/j.addr.2015.11.001

  • CrossRef
  • Google Scholar

• 256

  ThompsonW. R.RubinC. T.RubinJ. (2012). Mechanical regulation of signaling pathways in bone. Gene503, 179–193. 10.1016/j.gene.2012.04.076

  • CrossRef
  • Google Scholar

• 257

  ThomsonJ. A.Itskovitz-EldorJ.ShapiroS. S.WaknitzM. A.SwiergielJ. J.MarshallV. S.et al (1998). Embryonic stem cell lines derived from human blastocysts. Science282, 1145–1147. 10.1126/science.282.5391.1145

  • CrossRef
  • Google Scholar

• 258

  ToW. S.MidwoodK. S. (2011). Plasma and cellular fibronectin: Distinct and independent functions during tissue repair. Fibrogenes. Tissue Repair4, 21. 10.1186/1755-1536-4-21

  • CrossRef
  • Google Scholar

• 259

  TolarJ.AkemiI. Y.RiddleM.McElmurryR. T.OsbornM.XiaL.et al (2009). Amelioration of epidermolysis bullosa by transfer of wild-type bone marrow cells. Blood113, 1167–1174. 10.1182/blood-2008-06-161299

  • CrossRef
  • Google Scholar

• 260

  TolarJ.WagnerJ. E. (2013). Allogeneic blood and bone marrow cells for the treatment of severe epidermolysis bullosa: Repair of the extracellular matrix. Lancet382, 1214–1223. 10.1016/S0140-6736(13)61897-8

  • CrossRef
  • Google Scholar

• 261

  TorsoniA. S.ConstancioS. S.NadruzW.HanksS. K.FranchiniK. G. (2003). Focal adhesion kinase is activated and mediates the early hypertrophic response to stretch in cardiac myocytes. Circ. Res.93, 140–147. 10.1161/01.RES.0000081595.25297.1B

  • CrossRef
  • Google Scholar

• 262

  TraisterA.AafaqiS.MasseS.DaiX.LiM.HinekA.et al (2012). ILK induces cardiomyogenesis in the human heart. PLoS ONE7, e37802. 10.1371/journal.pone.0037802

  • CrossRef
  • Google Scholar

• 263

  TripathiA.KhanM. S.KhanA. R.VaughnV. M.BolliR. (2021). Cell therapy for nonischemic dilated cardiomyopathy: A systematic review and meta-analysis of randomized controlled trials. Stem Cells Transl. Med.10, 1394–1405. 10.1002/sctm.21-0094

  • CrossRef
  • Google Scholar

• 264

  TsaiS. W.ChengY. H.ChangY.LiuH. L.TsaiW. B. (2010). Type I collagen structure modulates the behavior of osteoblast-like cells. J. Taiwan Inst. Chem. Eng.41, 247–251. 10.1016/j.jtice.2009.10.002

  • CrossRef
  • Google Scholar

• 265

  TyagiS. C.KumarG., S.GloverG. (1995). Induction of tissue inhibitor and matrix metalloproteinase by serum in human heart‐derived fibroblast and endomyocardial endothelial cells. J. Cell. Biochem.58, 360–371. 10.1002/jcb.240580309

  • CrossRef
  • Google Scholar

• 266

  UittoJ.RichardG. (2004). Progress in epidermolysis bullosa: Genetic classification and clinical implications. Am. J. Med. Genet. C Semin. Med. Genet.131C, 61–74. 10.1002/ajmg.c.30035

  • CrossRef
  • Google Scholar

• 267

  UrciuoloA.QuartaM.MorbidoniV.GattazzoF.MolonS.GrumatiP.et al (2013). Collagen VI regulates satellite cell self-renewal and muscle regeneration. Nat. Commun.4, 1964. 10.1038/ncomms2964

  • CrossRef
  • Google Scholar

• 268

  VasioukhinV.BauerC.DegensteinL.WiseB.FuchsE. (2001). Hyperproliferation and defects in epithelial polarity upon conditional ablation of α-catenin in skin. Cell.104, 605–617. 10.1016/S0092-8674(01)00246-X

  • CrossRef
  • Google Scholar

• 269

  ViningK. H.MooneyD. J. (2017). Mechanical forces direct stem cell behaviour in development and regeneration. Nat. Rev. Mol. Cell. Biol.18, 728–742. 10.1038/nrm.2017.108

  • CrossRef
  • Google Scholar

• 270

  VleminckxK. (2017). “Cell adhesion molecules,” in Encyclopedia of cancer. Editor SchwabM. (Berlin Heidelberg: Springer), 885–891. 10.1007/978-3-662-46875-3_989

  • CrossRef
  • Google Scholar

• 271

  VogelV.SheetzM. (2006). Local force and geometry sensing regulate cell functions. Nat. Rev. Mol. Cell. Biol.7, 265–275. 10.1038/nrm1890

  • CrossRef
  • Google Scholar

• 272

  VolkS. W.ShahS. R.CohenA. J.WangY.BrissonB. K.VogelL. K.et al (2014). Type III collagen regulates osteoblastogenesis and the quantity of trabecular bone. Calcif. Tissue Int.94, 621–631. 10.1007/s00223-014-9843-x

  • CrossRef
  • Google Scholar

• 273

  WadeR.BohlJ.Vande PolS. (2002). Paxillin null embryonic stem cells are impaired in cell spreading and tyrosine phosphorylation of focal adhesion kinase. Oncogene21, 96–107. 10.1038/sj.onc.1205013

  • CrossRef
  • Google Scholar

• 274

  WangL. D.WagersA. J. (2011). Dynamic niches in the origination and differentiation of haematopoietic stem cells. Nat. Rev. Mol. Cell. Biol.12, 643–655. 10.1038/nrm3184

  • CrossRef
  • Google Scholar

• 275

  WangW.PanH.MurrayK.JeffersonB. S.LiY. (2009). Matrix metalloproteinase-1 promotes muscle cell migration and differentiation. Am. J. Pathol.174, 541–549. 10.2353/ajpath.2009.080509

  • CrossRef
  • Google Scholar

• 276

  WangY.ZhaoL.SmasC.SulH. S. (2010). Pref-1 interacts with fibronectin to inhibit adipocyte differentiation. Mol. Cell. Biol.30, 3480–3492. 10.1128/mcb.00057-10

  • CrossRef
  • Google Scholar

• 277

  WangZ.SuX.AshrafM.KimI. M.WeintraubN. L.JiangM.et al (2018). Regenerative therapy for cardiomyopathies. J. Cardiovasc. Transl. Res.11 (5), 357–365. 10.1007/s12265-018-9807-z

  • CrossRef
  • Google Scholar

• 278

  WattF. M.HoganB. L. M. (2000). Out of eden: Stem cells and their niches. Science287, 1427–1430. 10.1126/science.287.5457.1427

  • CrossRef
  • Google Scholar

• 279

  WattF. M.HuckW. T. S. (2013). Role of the extracellular matrix in regulating stem cell fate. Nat. Rev. Mol. Cell. Biol.14, 467–473. 10.1038/nrm3620

  • CrossRef
  • Google Scholar

• 280

  WattersA. K.RomS.HillJ. D.DematatisM. K.ZhouY.MerkelS. F.et al (2015). Identification and dynamic regulation of tight junction protein expression in human neural stem cells. Stem Cells Dev.24, 1377–1389. 10.1089/scd.2014.0497

  • CrossRef
  • Google Scholar

• 281

  WhiteD. E.KurpiosN. A.ZuoD.HassellJ. A.BlaessS.MuellerU.et al (2004). Targeted disruption of beta1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction. Cancer Cell.6, 159–170. 10.1016/j.ccr.2004.06.025

  • CrossRef
  • Google Scholar

• 282

  WishartA. L.ConnerS. J.GuarinJ. R.FatherreeJ. P.PengY.McGinnR. A.et al (2020). Decellularized extracellular matrix scaffolds identify full-length collagen VI as a driver of breast cancer cell invasion in obesity and metastasis. Sci. Adv.6, eabc3175. 10.1126/sciadv.abc3175

  • CrossRef
  • Google Scholar

• 283

  WoessnerJ. F. (1991). Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J.5, 2145–2154. 10.1096/fasebj.5.8.1850705

  • CrossRef
  • Google Scholar

• 284

  WolfensonH.YangB.SheetzM. P. (2019). Steps in mechanotransduction pathways that control cell morphology. Annu. Rev. Physiol.81, 585–605. 10.1146/annurev-physiol-021317-121245

  • CrossRef
  • Google Scholar

• 285

  WoodsA. (2001). Syndecans: Transmembrane modulators of adhesion and matrix assembly. J. Clin. Invest.107, 935–941. 10.1172/JCI12802

  • CrossRef
  • Google Scholar

• 286

  WyattJ.VogelsangH.HüblW.WaldhoerT.LochsH. (1993). Intestinal permeability and the prediction of relapse in Crohri’s disease. Lancet341, 1437–1439. 10.1016/0140-6736(93)90882-H

  • CrossRef
  • Google Scholar

• 287

  XiaM.ChenY.HeY.LiH.LiW. (2020). Activation of the RhoA-YAP-β-catenin signaling axis promotes the expansion of inner ear progenitor cells in 3D culture. Stem Cells38, 860–874. 10.1002/stem.3175

  • CrossRef
  • Google Scholar

• 288

  XiaopingC.YongL. (2009). Role of matrix metalloproteinases in skeletal muscle: Migration, differentiation, regeneration and fibrosis. Cell. Adh. Migr.3 (4), 337–341. 10.4161/cam.3.4.9338

  • CrossRef
  • Google Scholar

• 289

  YangX.WangH.JiaoB. (2017). Mammary gland stem cells and their application in breast cancer. Oncotarget8, 10675–10691. 10.18632/oncotarget.12893

  • CrossRef
  • Google Scholar

• 290

  YeoG. C.WeissA. S. (2019). Soluble matrix protein is a potent modulator of mesenchymal stem cell performance. Proc. Natl. Acad. Sci. U. S. A.116, 2042–2051. 10.1073/pnas.1812951116

  • CrossRef
  • Google Scholar

• 291

  YlönenR.KyrönlahtiT.SundM.IlvesM.LehenkariP.TuukkanenJ.et al (2005). Type XIII collagen strongly affects bone formation in transgenic mice. J. Bone Min. Res.20, 1381–1393. 10.1359/JBMR.050319

  • CrossRef
  • Google Scholar

• 292

  YonekawaT.NishinoI. (2015). Ullrich congenital muscular dystrophy: Clinicopathological features, natural history and pathomechanism(s). J. Neurol. Neurosurg. Psychiatry86, 280–287. 10.1136/jnnp-2013-307052

  • CrossRef
  • Google Scholar

• 293

  YonemuraS.WadaY.WatanabeT.NagafuchiA.ShibataM. (2010). alpha-Catenin as a tension transducer that induces adherens junction development. Nat. Cell. Biol.12, 533–542. 10.1038/ncb2055

  • CrossRef
  • Google Scholar

• 294

  YuJ.ThomsonJ. A. (2008). Pluripotent stem cell lines. Genes. Dev.22, 1987–1997. 10.1101/gad.1689808

  • CrossRef
  • Google Scholar

• 295

  YuanJ.WeiZ.XuX.OcanseyD. K. W.CaiX.MaoF. (2021). The effects of mesenchymal stem cell on colorectal cancer. Stem Cells Int., 9136583. 10.1155/2021/9136583

  • CrossRef
  • Google Scholar

• 296

  YueB. (2014). Biology of the extracellular matrix: An overview. J. Glaucoma23, S20–S23. 10.1097/IJG.0000000000000108

  • CrossRef
  • Google Scholar

• 297

  YuiS.NakamuraT.SatoT.NemotoY.MizutaniT.ZhengX.et al (2012). Functional engraftment of colon epithelium expanded in vitro from a single adult Lgr5⁺ stem cell. Nat. Med.18, 618–623. 10.1038/nm.2695

  • CrossRef
  • Google Scholar

• 298

  ZeissigS.BürgelN.GünzelD.RichterJ.MankertzJ.WahnschaffeU.et al (2007). Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn’s disease. Gut56, 61–72. 10.1136/gut.2006.094375

  • CrossRef
  • Google Scholar

• 299

  ZhangN.XieX.ChenH.ChenH.YuH.WangJ. A. (2014). Stem cell-based therapies for atherosclerosis: Perspectives and ongoing controversies. Stem Cells Dev.23, 1731–1740. 10.1089/scd.2014.0078

  • CrossRef
  • Google Scholar

• 300

  ZigrinoP.BrinckmannJ.NiehoffA.LuY.GiebelerN.EckesB.et al (2016). Fibroblast-Derived MMP-14 regulates collagen homeostasis in adult skin. J. Invest. Dermatol.136, 1575–1583. 10.1016/j.jid.2016.03.036

  • CrossRef
  • Google Scholar